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CHAPTER 1
Hypoxia-induced Damage to the Adult and Immature Brain: Molecular Mechanism
of Oxidative Damage
1 Neuropathology of Reperfusion Injury
Brain ischemia/reperfusion results in extensive injury and is a substantial medical
burden because of the ensuing morbidity and mortality. In adults, ischemic insults to
the brain typically result from stroke (caused by either thrombotic occlusion or rupture of
a blood vessel) or cardiac arrest while, in infants, cerebral ischemia is initiated by
complications during labor and delivery, resulting in neonatal hypoxic-ischemic
encephalopathy. In both cohorts, restoring blood flow and thus reestablishing nutrient
and oxygen delivery to the ischemic brain will undoubtedly salvage neurons. However,
reperfusion itself causes additional, substantial brain damage termed “reperfusion
injury”. The impact of cerebral ischemia/reperfusion injury on patient mortality is sizable
irrespective of age or etiology.
1.1 Stroke
Stroke is the third leading cause of death and disability among Americans [1].
Strokes are most commonly ischemic in origin, caused by vascular obstruction in the
cerebral circulation. If diagnosed in a timely manner, ischemic stroke can be reversed
by administration of thrombolytic agents or, alternatively, the obstruction can be
physically removed. Neurons that lie distal to the obstructed vessel, relying exclusively
on blood supply from this vessel, die from the prolonged complete ischemia. These
neurons comprise the infarcted region of the brain that is termed the “ischemic core”.
Such neurons never regain function upon restoration of blood flow, and are dead prior
to any window of therapeutic intervention.

Of greater clinical interest are the

populations of neurons that die in a delayed manner after reperfusion is initiated. These
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neurons, surrounding the ischemic core - referred to as the “penumbra” - are in part
perfused by collateral blood flow (i.e., are not fully reliant on blood flow from the
obstructed vessel), and are therefore more resistant to ischemic damage. Although
neurons of the penumbra do not succumb to the initial ischemia-induced cell death, they
go on to die during reperfusion in a delayed manner via mechanisms that resemble an
apoptotic pathway. The delay in death of these cells offers a window for therapeutic
intervention, thus it is critical that treatment of the penumbra be considered prior to
recanalization of the obstructed vessel.
1.2 Cardiac Arrest/Resuscitation
Another leading cause of brain ischemia/reperfusion injury is cardiac arrest
followed by resuscitation. In contrast to a focal brain insult caused by stroke, cardiac
arrest results in complete ischemia throughout the entire brain.

The brain is an

extremely sensitive organ, hence even short durations of global ischemia (beyond 10
minutes) can result in debilitating neurologic deficits [2]. This sensitivity to ischemia
may result from reliance on oxidative phosphorylation (OxPhos) for energy production, a
concept we will address in detail in subsequent sections.
Successful resuscitation can rapidly restore blood flow and oxygen delivery to the
body, including the brain. While approximately 70,000 patients are resuscitated from
cardiac arrest each year, only ~10-35% of resuscitated patients survive to hospital
discharge; this excessive death is likely a result of the severe brain damage caused by
cerebral ischemia [2-4]. Whereas stroke results in a cerebral infarct, resuscitation from
cardiac arrest results in neuronal death in select cell populations that are most sensitive
to ischemic injury. The most sensitive populations of neurons, the CA1 hippocampal
neurons [5, 6], die during the first days of reperfusion [7, 8]. The specific biochemical
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events that result in delayed neuronal death continue to be elucidated; however,
overwhelming evidence has identified reactive oxygen species (ROS) generation as a
key damaging event that leads to death of neurons [9-12].
1.3 Neonatal Hypoxic-Ischemic Encephalopathy
Ischemic insults to the infant brain cause hypoxic-ischemic encephalopathy
(HIE), which leads to long-term neurocognitive deficits including cerebral palsy and
epilepsy [13]. With an occurrence of approximately 2-4 per 1000 full-term in-hospital
deliveries, HIE is a serious medical concern.

The consequences of HIE are more

severe among low birth weight and premature newborns [14, 15]. Various antepartum
causes of HIE have been identified including maternal hypotension and fetal growth
restriction, yet, the most prevalent cause is prolapse or compression of the umbilical
cord and placenta abruption [16-18].

There is extensive heterogeneity in

neuropathology following HIE, primarily due to variation in the etiology and severity of
the hypoxic/ischemic events [19]. However, as in the adult, reperfusion undoubtedly
contributes significantly to the overall pathologic progression of HIE and thus is of
therapeutic interest.
2. A Mitochondrial Perspective on Reperfusion Injury
Mitochondria have long been known to play a critical role in the pathogenesis of
cerebral ischemia/reperfusion injury, via ROS generation, mitochondrial failure or
dysfunction,

and

mitochondrial

(type

II)

apoptosis.

In

fact,

during

brain

ischemia/reperfusion evidence exists for the three above deleterious events occurring
within the mitochondria (see [20, 21]). The goal of Chapter 1 is to present a hypothesis
developed largely in the Sanderson and Hüttemann laboratories and propose a
common link between the three above events in mitochondrial pathologies seen during
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stroke, cardiac arrest, and HIE. In Section 3 the hypothesis is extended to unify these
three events into a novel paradigm that positions OxPhos as a central linchpin in the
initiation and execution of cell death caused by ischemia/reperfusion. However, before
presenting this model of reperfusion injury, it is critical that we discuss: 1) how the
OxPhos system functions; 2) the mechanism by which OxPhos generates and controls
the mitochondrial membrane potential (∆Ψm); 3) control of OxPhos by phosphorylation;
and finally 4) the role of the ∆Ψm in ROS generation.
2.1 The Electron Transport Chain and Oxidative Phosphorylation
The mitochondrial electrochemical gradient or protonmotive force (∆pm) is
generated and utilized by the OxPhos system, composed of the electron transport chain
(ETC) and ATP synthase. A primary function of the ETC is to execute the transfer of
electrons to the final electron acceptor, O2. The molecular machinery that comprise the
ETC include two major sites for electron entry, complex I (NADH dehydrogenase), and
complex II (succinate dehydrogenase). Electrons donated to either of these protein
complexes are transferred to complex III (bc1 complex) via the non-protein electron
carrier ubiquinone.

Electrons are transferred from complex III to complex IV

(cytochrome c oxidase, CcO) via the electron carrier cytochrome c.
CcO catalyses the final, and proposed rate limiting step in electron transfer; the
donation of electrons to O2, allowing conversion of O2 and H+ to H2O. The energy
stored in the electrons is stepwise extracted by complexes I, III, and IV, which couple
electron transfer along the ETC to pumping of H+ across the inner mitochondrial
membrane.

This pumping of protons across the inner mitochondrial membrane

constitutes the largest contributing force of the mitochondrial membrane potential
(∆Ψm), representing the overall charge difference across the inner mitochondrial
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membrane (see Section 2.2). In addition, these chemical protons that are taken up from
the matrix site contribute to the generation of ∆pm. Finally, ∆pm is utilized by ATP
synthase (complex V), which drives the conversion of ADP and Pi to ATP (Figure 1-1).
This process provides the vast majority (90%) of ATP in the brain under normal
conditions.
Figure 1-1: The Mitochondrial Electron
Transport
Chain
and
Oxidative
Phosphorylation. The mitochondrial OxPhos
components include: complex I (NADH
dehydrogenase),
complex
II
(succinate
dehydrogenase complex III (bc1 complex),
complex IV (cytochrome c oxidase, CcO) and
complex V (ATP synthase). Electrons donated to
either complex I or complex II are transferred to
complex III via the non-protein electron carrier
ubiquinone. From there, electrons are transferred
to complex via cytochrome c. Electron flux
through complexes I, III, and IV is couple to the
pumping of H+ across the inner mitochondrial
membrane. The generation of a proton gradient
across the inner mitochondrial membrane drives
the conversion of ADP and Pi to ATP by complex
IV.

Under non-stressed conditions, the transfer of electrons is a tightly regulated
process. In fact, the vast majority of electrons that are donated to the ETC complete the
entire reaction, culminating in reduction of O2.

However, a small percentage of

electrons escape the ETC and can react with O2 to form superoxide (O2-), a potent ROS.
The specific sites of ROS generation along the ETC are complexes I and III. Although
CcO (complex IV) produces several radical intermediates during the reduction of O2, no
electrons are allowed to escape; as a result CcO does not directly produce ROS. Under
normal conditions, endogenous antioxidant systems are sufficient to scavenge the
modest amounts of ROS generated and prevent cellular damage.

However, under

pathologic conditions antioxidants become overwhelmed or exhausted, allowing the
unopposed and uncontrolled production of ROS and resultant ROS-initiated damage to
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cellular proteins, lipids, nucleic acids, and polysaccharides in an indiscriminate fashion
[22-26]. To fully understand how ROS generation occurs and how this is controlled in a
normal physiologic context, an appreciation of ∆pm and its primary component, the
mitochondrial membrane potential ∆m, is required.
2.2 The Proton Motive Force and Mitochondrial Membrane Potential
∆pm consists of two components, 1) an electrical constituent, simply referred to as
the mitochondrial membrane potential ∆Ψm, and 2) a chemical constituent, the pH
difference across the inner mitochondrial membrane. Their relationship is defined as
∆pm = ∆Ψm - 59 ∆pH. The electrical component, ∆Ψm, represents the major portion of
∆pm in higher organisms.
In the traditional view, ∆pm (and ∆Ψm) are determined by two basic components,
substrate availability and respiratory control, which both act on the OxPhos complexes.
The most basic means of mitochondrial OxPhos regulation is dependent on both
availability of substrate (e.g., NADH, O2, ADP, Pi) and its product, ATP. ATP and ADP
are allosteric inhibitors and activators of CcO, respectively, and this control mechanism
was proposed to adjust ETC activity to energy demand [27, 28]. Another major OxPhos
regulatory mechanism is provided by ∆pm itself, and is called respiratory control, as was
demonstrated in isolated mitochondria more than five decades ago [29]. Respiratory
control is a mechanism by which ∆pm causes inhibition of the ETC proton pumps when
the proton gradient exceeds a threshold value, preventing further proton pumping at
high ∆pm levels. When ATP synthase converts ADP to ATP by utilizing the proton
gradient, the reduction in ∆pm allows the proton pumps (i.e., complexes I, III, and IV) to
resume electron transfer and to pump protons across the inner membrane. In resting
mitochondria, when the vast majority of ADP has been converted into ATP, synthesis of
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ATP slows and ∆pm increases, inhibiting the proton pumps and thus mitochondrial
respiration. This feedback mechanism pairs the ETC activity to ∆m and serves to
maintain ∆m at physiologic levels of 80-140mV - a range in which ATP production is
efficient and ROS generation is minimal.
Due to the difficulty of measuring absolute ∆pm in intact cells, most publications
report ∆Ψm values, which constitute the majority of ∆pm. ∆Ψm can be monitored in living
cells using voltage-dependent fluorescent probes such as the rhodamine dye TMRE
(tetramethyl-rhodamine ethyl ester), and changes in fluorescence indicate relative
changes in ∆Ψm. Absolute ∆Ψm levels in millivolts can also be determined in isolated
mitochondria by measuring the distribution of a membrane permeable cation such as
tetraphenylphosphonium (TPP) with a TPP-sensitive electrode. In addition, absolute
mV values for ∆Ψm can be determined in live cells by monitoring the redox states of the
redox centers in bc1 complex, thus allowing the precise calculation of ∆Ψm [30].
Since ∆Ψm could be measured readily, studies investigating ∆Ψm revealed an
important difference of ∆Ψm levels observed in isolated mitochondria versus intact cells.
In isolated mammalian mitochondria from liver and brain under state 4 conditions, ∆Ψm
values were measured ≥150 mV, often exceeding 200 mV [31-38]. In contrast, the
majority of studies performed in a more physiological context with a variety of intact
mammalian cells or even intact organs showed lower ∆Ψm values in the range of 80 to
140 mV [39-43], with few studies reporting higher values between 140 – 161 mV [41,
43-47]. This discrepancy may be explained by differences in the regulation of OxPhos
activity in higher organisms.
Respiratory control has traditionally been viewed as a key regulator of OxPhos.
While this may be correct for OxPhos systems in bacteria, it appears that, in
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eukaryotes, additional regulatory mechanisms are in place.

This idea is further

supported by the fact that OxPhos enzymes are more complex in higher organisms.
For example, CcO from bacteria contains 2 to 4 subunits whereas the mammalian
enzyme is composed of 13 subunits per monomer and functions as a dimer, suggesting
divergence with enhanced regulation [48, 49].

Although some differences between

studies may be explained by different experimental conditions and the use of cells from
different species and tissues, the emerging picture is that ∆Ψm values in isolated
mitochondria are higher compared to those in intact cells.

Explanations for this

discrepancy, and the consequences of high ∆Ψm values, will be discussed in the next
two sections.
2.3 OxPhos is Regulated by Reversible Phosphorylation
Higher ∆Ψm values observed in isolated mitochondria compared to intact cells
suggest that the isolation procedure per se may induce modifications resulting in
readings above the true physiologic range.

Importantly, all mammalian OxPhos

complexes are phosphorylated in vivo (reviewed in [50]), and we propose that these
phosphorylations may be lost during traditional mitochondria isolation. A recent study
analyzing mitochondrial morphology and function showed that the structure of isolated
mitochondria is clearly different compared to the morphology found in vivo [51]. The
authors further demonstrated a ~2-fold increase in CcO activity. Calcium is a buffer
component used in some traditional protocols to purify mitochondria, and is a highly
potent physiological second messenger and activator of mitochondrial function [52].
Calcium was shown to trigger dephosphorylation of most mitochondrial proteins [53],
which may be mediated by calcium-dependent phosphatases as the Hüttemann
laboratory and others have postulated [50, 54, 55]. A similar scenario likely takes place
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during ischemic stress, and this will be the focus of Section 3.
The Hüttemann and Sanderson groups have proposed that phosphorylation of
OxPhos complexes is a critical regulatory mechanism in higher organisms to maintain
healthy respiration rates and to prevent hyperpolarization of ∆Ψm. Using novel methods
of mitochondrial and OxPhos protein isolation that preserve protein phosphorylation
sites [56], cytochrome c and CcO were found to be reversibly phosphorylated at multiple
residues [57-59]. Moreover, phosphorylation of these proteins altered their electron
transfer

kinetics

and

affected

allosteric

regulation

by

ATP

and

ADP

[57].

Phosphorylation of cytochrome c at either Tyr48 and Tyr97, caused reduced reaction
rates with CcO, and is proposed to lead to normal physiologic electron transfer rates
[60-62]. In all tissue types investigated, cytochrome c was normally present in both the
phosphorylated and dephosphorylated state. Upon cellular stress (specifically, cerebral
ischemia), the enzyme is rapidly dephosphorylated [63]. Interestingly, activation of cell
signaling cascades that promote cell survival, such as insulin signaling [64], induce
cytochrome c phosphorylation [63].

A residue on CcO was also identified that is

reversibly phosphorylated (Tyr304), leading to inhibition of CcO [54].

Thus,

dephosphorylation of CcO results in higher basal respiration.
The hypothesis was further expanded to propose that mitochondrial isolation
procedures or cellular stress, including ischemia, alter the physiological phosphorylation
state of the OxPhos complexes. This concept is supported by a study demonstrating
hypoxia-induced changes in CcO phosphorylation in the heart [65].

In this model,

phosphorylation of OxPhos proteins induce a healthy respiratory state where m
values >140 mV inhibit further proton pumping, maintaining the 80-140 mV range where
ROS production is minimal.

In contrast, cellular stress in vivo and isolation of

10
mitochondria in vitro causes changes and/or dephosphorylations of ETC complexes
promoting maximal activity, and m only inhibits further proton pumping at very high
∆Ψm values; thus, in this state m is hyperpolarized. Support for the proposed model
is provided by studies showing that phosphorylation of CcO and cytochrome c, as found
in vivo, leads to partial inhibition and thus healthy cell respiration [54, 60, 66].
These studies demonstrate that stressful stimuli, such as ischemia, can result in
changes in phosphorylation pattern of the OxPhos complexes, leading to ROS
generation. Conversely, survival signaling promotes phosphorylation and ‘controlled’
electron transfer rates.

Novel findings reported by Hüttemann et al. suggest a

mechanism by which cell signaling cascades can regulate the overall basal activity rate
of OxPhos [58]. Similar regulatory mechanisms may be discovered on other OxPhos
complexes and functionally studied in the future. It is our hypothesis that mitochondria
in intact cells under healthy conditions do not function at maximal capacity. This is
reasonable because: 1) maximal rates of ATP synthesis by ATP synthase occur at
∆Ψm=100-120 mV [67]; thus a further increase in ∆Ψm will not result in more ATP
production, and 2) as discussed in Section 2.4, high ∆Ψm levels cause excessive ROS
production.
2.4 Mitochondrial Membrane Potential Controls ROS Production
Under normal conditions, over 90% of oxygen is fully reduced to H2O by CcO and
only a small number of electrons ‘leak’ and lead to partial reduction of O2 to superoxide.
This ROS production takes place proximal to CcO, at complexes I and III, which release
superoxide on the matrix and intermembrane space sides, respectively [68]. In complex
I, two major sites of electron escape have been proposed, the flavoprotein component
of electron entry into complex I [69] or the iron-sulfur cluster [70]. For complex III, ROS
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is produced by inhibition of electron transfer through the Q cycle [71]. Electron transfer
from the cytochrome bL heme to the bH heme is inhibited at high ∆Ψm, resulting in
ubisemiquinone radical generation [72].

Ubisemiquinone generated near the

intermembrane space then reduces O2 to form superoxide.
Electron leak occurs at complex I, complex III, or both, depending on the type of
stressful stimuli and cell type, however one common mechanism exists. It has been
clearly demonstrated that ROS generation is dependent on ∆Ψm. Specifically: 1) the
maintenance of physiologically optimal ∆Ψm values, not exceeding 140 mV, prevents
generation of ROS, while providing the full capability to produce ATP [67]; 2) although
there are some conditions where ROS can be generated at low ∆Ψm levels through
different mechanisms [73], it is generally accepted that pathophysiologic levels of ROS
are produced at high ∆Ψm values; and 3) hyperpolarization of ∆Ψm (exceeding 140 mV)
causes an exponential increase in ROS generation at both complexes I and III [71, 7476]. It was also shown that the ∆Ψm component alone, and not ∆pH of the proton
motive force, determines ROS production at complex III [77]. High ∆Ψm levels extend
the half-life of reaction intermediates of electron transfer at sites capable of single
electron reduction of O2, thus allowing electron escape.
Once partially reduced to superoxide, this oxygen radical reacts with other
molecules such as H2O or H+ to generate even more reactive species H2O2, HO2, and
OH. In addition, superoxide interacts with NO to form equally cytotoxic reactive nitrogen
species. ROS generated in the mitochondria can freely cross mitochondrial membranes
or exit via mitochondrial channels such as VDAC and, once released, can cause
oxidative damage throughout the cell.

Of note, ROS react quickly (half-life of

nanoseconds to seconds) and irreversibly to damage cell constituents.
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An important question remains: why do mitochondria have an excess capacity to
generate higher ∆Ψm levels with potentially disastrous consequences for the cell? One
reason is that mitochondria must have the capacity to adapt to varying energy
demands. However, a more plausible explanation is their involvement in mitochondrial
(type II) apoptosis. Numerous studies have demonstrated that induction of apoptosis,
which is accompanied by stress signaling and can involve: 1) excessive calcium
release; 2) transient hyperpolarization of ∆Ψm; and 3) a burst in the production of ROS,
which has been proposed as a key signal for committing a cell to apoptosis (reviewed in
[78]). Accordingly, in Sections 3 and 4, this mitochondrial-centric sequence of events
leading to cellular demise is integrated into a model of ischemia/reperfusion injury, and
the concept that modulation of ∆Ψm may provide a novel strategy to attenuate brain
damage caused by ischemia/reperfusion is discussed.
3. Model of Ischemia/Reperfusion Injury
The preceding sections have provided insight regarding the role of mitochondria in
cell death caused by brain ischemia/reperfusion, and are consistent with a hypothesis
that focuses on changes of the phosphorylation state of mitochondrial OxPhos and
subsequent ∆Ψm hyperpolarization (Figure 1-2).

This model predicts that ischemic

alterations of mitochondrial OxPhos primes the mitochondria for reperfusion-induced
∆Ψm hyperpolarization, an associated burst in mitochondrial ROS generation and loss
of mitochondrial function, and subsequent delayed neuronal death. This progression is
simplified into four main states that summarize the induction, progression, and
execution of cell death during brain ischemia/reperfusion: 1) ischemic starvation; 2)
reperfusion-induced hyperactivation; 3) mitochondrial dysfunction; and 4) delayed
neuronal death (Figure 1-2).
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Figure 1-2: Progression of Ischemia/reperfusion Injury. (A) Under normal, non-stressed conditions,
OxPhos components are phosphorylated (as illustrated for cytochrome c and CcO), promoting controlled
electron transfer and maintaining the ∆Ψm in the 80-140mV range. This respiratory state is conducive to
maximal ATP production and minimal ROS generation. (B) Ischemia induces a starvation state were the
ETC cannot function due to lack of O2. Dephosphorylation of OxPhos during ischemia renders these
enzymes ‘primed’ for hyperactivity, however they cannot operate due to lack of the terminal substrate for
respiration, O2. (C) Reintroduction of O2 with reperfusion initiates electron transfer, proton pumping and
ATP synthesis. However, in this hyperactive (dephosphorylated) state, OxPhos hyperpolarizes the ∆Ψm,
causing an exponential increase in ROS generation at complexes I and/or III. (D) This burst in ROS can
act as a signal for triggering apoptosis. In addition, damage caused by ROS induces a mitochondrial
dysfunction state, with reduced electron transfer kinetics and reduced ∆Ψm levels, which results in
energetic failure.

3.1 Ischemic-Starvation State: Ischemic OxPhos Dephosphorylation and the Role
of Calcium
A unique feature of the brain is that it is almost exclusively dependent on
oxidative phosphorylation to generate energy.

Therefore it is necessary to have a

constant supply of oxygen to sustain functionality. As discussed in previous sections,
even under normal conditions, oxidative phosphorylation results in low-level production
of ROS which immediately react with antioxidants and do not cause measurable cellular
damage. Brain ischemia of even short durations (on the order of seconds-minutes)
causes cessation of electron transport, as OxPhos cannot proceed under anoxic
conditions. Electron stalling occurs when the rate of entry of electrons into complex I
exceeds the rate of transit through the slowest step of the chain. During ischemia,
limiting electron transit through complex IV causes upstream build-up of electrons at
complexes I and III, thus leading to reduced ETC.
Without electron transfer and proton pumping across the inner mitochondrial
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membrane, the proton gradient quickly dissipates, thereby disabling ∆pm-driven ATP
generation by ATP synthase. Ischemia has been found to cause depolarization of ∆Ψm
following simulated ischemia in vitro [79] and in vivo during experimental stroke [80]. If
ischemia persists, this eventually leads to ATP depletion and failure of all energydependent processes in the mitochondria and throughout the cell [81, 82]. Depletion of
ATP during ischemia would not allow ATP synthase to maintain ∆Ψm by operating in the
reverse mode via ATP hydrolysis, a mechanism that operates under certain conditions
such as in some cancer cells [83], where it is driven by high ATP flux through glycolysis.
Of particular importance to ischemia/reperfusion injury is the equilibration of Ca2+ across
the plasma membrane and subsequent accumulation of Ca2+ in the cytosol. At high
cytosolic [Ca2+], mitochondria actively sequester Ca2+ to prevent pathologic increases in
cytosolic [Ca2+].

However, under the condition of ischemic depolarization,

intramitochondrial [Ca2+] increases to pathologic levels with evidence (by electron
microscopy) of severe mitochondrial swelling and accompanying hallmarks of cell death
[84].
Calcium is a potent activation signal for mitochondrial phosphatases.
example,

the

calcium-dependent

Ser/Thr-phosphatase,

calcineurin,

For
can

dephosphorylate proteins within the mitochondria [85]. Indeed, Ca2+ accumulation in
the mitochondria induces dephosphorylation of multiple mitochondrial proteins [53, 57].
Moreover, it has been demonstrated that increased mitochondrial Ca2+ is a potent
activation signal for mitochondrial respiration, leading to increased respiration and
excessive ROS generation.

This scenario is consistent with that suggested by

McCormack and Denton who postulated that the main role of increased mitochondrial
Ca2+ is to stimulate ATP production by activating enzymes involved in metabolism [86].
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The effect of Ca2+ on mitochondrial respiration does not appear to be due to a direct
action of Ca2+ on ETC components, suggesting an intermediate step exists that could
be activated by Ca2+.

The recent discoveries that dephosphorylation of CcO and

cytochrome c lead to increased respiration rates provide a potential explanation for
these early observations of the effect of Ca2+ on mitochondrial metabolism.
The proposed model represents a pathologic alteration as a response to an
imbalance between energy availability and energy demand. Under conditions of mild
hypoxia and inadequate ATP, energy demand would trigger Ca2+ signaling to increase
mitochondrial respiration to increase ATP production in order to correct the deficiencies
[87]. In contrast, under ischemic conditions, attempts to increase OxPhos activity in
response to inadequate ATP are futile, as the final electron acceptor, O2, is not present.
One can speculate that this feed-forward mechanism caused by ischemia would
eventually promote maximal activation of OxPhos. Indeed, others have questioned how
a normal physiologic stimulus to increase energy production can lead to a pathologic
increase in ROS generation [88]. When this process is viewed in the context of OxPhos
dephosphorylation inducing subsequent hyperactivation of OxPhos, one can appreciate
how ischemia could promote a mitochondrial state where substantial ROS can be
generated upon reperfusion.
3.2 Reperfusion-Induced Hyperactivation State: OxPhos Hyperactivity, ∆Ψm
Hyperpolarization, and ROS Generation
It is obvious that reperfusion of the ischemic brain is necessary for any attempt to
salvage tissue.

However, as previously discussed, reperfusion per se contributes

significantly to tissue damage.

From the perspective of ischemic mitochondria,

reperfusion is necessary to restore the terminal substrate for OxPhos and nutrients to
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reinitiate cellular respiration. However, ischemia promotes a mitochondrial state that is
conducive to hyperactive electron transfer upon reperfusion (Figure 1-3).

Figure 1-3: Mechanism of ROS generation during reperfusion. During extended brain ischemia,
increased intramitochondrial Ca2+ activates phosphatases that dephosphorylate OxPhos components, as
shown for cytochrome c and CcO in B. This promotes a state of OxPhos hyperactivity; however, because
O2 is absent electron transport cannot proceed. (C) Upon induction of reperfusion, OxPhos is allowed to
operate at maximal activity, generating high ∆Ψm levels, which in turn promotes ROS generation.

According

to

the

proposed

model,

ischemia

evokes

an

increase

in

intermitochondrial Ca2+ [84, 89, 90], causing activation of mitochondrial phosphatases
and dephosphorylation of OxPhos complexes [53], most notably cytochrome c and CcO
(Figure 1-3). In addition to the effect on overall respiratory rate, dephosphorylation of
CcO also leads to loss of allosteric inhibition by ATP [54, 55, 57, 60, 66]. Increased
OxPhos activity alone could hyperpolarize ∆Ψm when reperfusion is initiated, and the
loss of allosteric inhibition by ATP would further exacerbate this hyperpolarization. This
effect could essentially ‘reset’ respiratory control to a higher level, leading to loss of
feedback inhibition between OxPhos and ∆Ψm at the normal 120-140mV range. Under
these conditions, hyperpolarization could be exacerbated and persist longer than
otherwise possible without OxPhos dephosphorylation.
Enhanced

and

prolonged

∆Ψm

hyperpolarization

would

have

dramatic

consequences. Liu et al. provided compelling evidence of the exponential nature of the
relationship between ROS and ∆Ψm (reviewed in [71]). When ∆Ψm exceeds 140 mV the
exponential nature becomes clear, resulting in a 70-90% increase in ROS generation
with a modest 10 mV increase in ∆Ψm [71, 74]. Experimental measurements of ∆Ψm in
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this elevated range are plausible.

In fact, as previously discussed, traditional

mitochondrial isolation methods that do not take into account preservation of OxPhos
phosphorylation often result in ∆Ψm above 200 mV [31-38]. These studies suggest that
OxPhos dephosphorylation during ischemia would have profound consequences when
reperfusion is initiated.
During the initial moments of reperfusion, OxPhos dephosphorylation would
serve to promote rapid reestablishment of ∆Ψm and restoration of cellular ATP levels.
Indeed, following reversal of brain ischemia, ∆Ψm is restored to contol levels within 1
minute, and cellular ATP levels are restored in less than 15 minutes [80]. However, if
normal respiratory control mechanims are lost (including loss of alosteric inhibtion by
ATP), ∆Ψm would surpass normal levels, resulting in pathologic ∆Ψm hyperpolarization.
In this regard, Liu et al. demonstrated that rapid restoration of ∆Ψm is quickly followed
by hyperpolarization of ∆Ψm. A study in neuronal cell culture exposed to simulated
ischemia/reperfusion injury demonstrated ∆Ψm hyperpolaization during the initial
reperfusion stages [91].

Moreover, inhibition of ∆Ψm hyperpolarization by blocking

complex I has been shown to prevent a stress-induced ROS burst and subsequent cell
death [92]. Finally, this concept was extended by Starkov and Fiskum, who reported
that mitochondria isolated from brain do, indeed, have an exponential relationship
between ∆Ψm and ROS when assayed in vitro [74]. These studies suggest a pathologic
condition where reperfusion results in ∆Ψm hyperpolarization which subsequently
causes a significant ROS burst upon reperfusion.
Additional support for the OxPhos paradigm is provided by evidence
demonstrating that the majority of ROS generation after brain ischemia occurs
immediately upon reflow. For example, in the setting of global brain ischemia, ROS
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generation is most pronounced during the first 15 minutes of reperfusion [93].
Moreover, the predominant source of these ROS are the mitochondrial OxPhos
complexes [11, 94, 95] and, in brain, escape of electrons from complex I appears to be
responsible for most of the ROS produced [95-98].
As discussed in Section 2.4, the pivotal event that drives excessive electron
escape and generation of ROS in vivo is ∆Ψm hyperpolarization. These data imply that
interventions aimed at regulating ∆Ψm and preventing hyperpolarization may serve to
attenuate ROS generation.

Of particular interest is the dephosphorylation and

hyperactivation of CcO, as CcO is the proposed rate-limiting step in OxPhos.
Alternatively, direct targeting of ∆Ψm (for example, by using mitochondrial membrane
uncoupling agents) may provide a feasible approach.

However, before considering

modulation of ∆Ψm as a therapeutic strategy (see Section 4), the cytotoxic
consequences of ROS generation are reviewed.
3.3 Mitochondrial Dysfunction
Early studies into mitochondrial function following brain ischemia/reperfusion
injury found that, by 30 minutes of reperfusion, mitochondrial respiration is dramatically
decreased in cell populations that are destined to die [99, 100]. More recent reports
have demonstrated that global brain ischemia/reperfusion leads to a reduction in
complex I and CcO activity at later stages of reperfusion. This respiratory inhibition
occurs within the first hour of reperfusion for CcO, and progresses more slowly for
complex I (i.e., maximal inhibition by 24 hours of reperfusion [101]).

This loss of

respiratory function is accompanied by a reduction and eventual collapse of ∆Ψm,
leading to cell death. Interestingly, while traditional studies have demonstrated reduced
OxPhos activity during later reperfusion, recent evidence by Chomova and colleagues
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has shown that, in the early minutes of reflow, OxPhos activities are increased over
control levels [102].

These studies suggest that our current understanding of the

responses of OxPhos to ischemia/reperfusion may be confounded by inappropriate
mitochondrial extraction techniques employed in older reports.
Mitochondrial dysfunction during reperfusion has often been attributed to ROSinduced damage of mitochondrial components [70, 103]. The resulting OxPhos hypoactivation state (Figure 1-2) results in impaired proton pumping and reduced electron
transfer kinetics.

The mitochondrial switch from a hyperactive to dysfunctional

hypoactive state has been attributed to oxidative damage of OxPhos complexes and/or
oxidative damage to lipids important to OxPhos function. In support of this concept,
direct oxidative damage of mitochondria has been shown to be involved in cellular
damage following brain ischemia/reperfusion [104, 105].
A critical mitochondrial lipid target of ROS damage is cardiolipin. This is a unique
phospholipid in that the majority of cardiolipin is found in the inner mitochondrial
membrane where it is in tight association with OxPhos components. Cardiolipin plays a
critical role in membrane insertion and function of cytochrome c, CcO, and other
OxPhos complexes [106, 107], and there is growing evidence that cardiolipin plays a
pivotal role in the regulation of mitochondrial bioenergetics [108, 109].

In fact,

alterations in the structure and/or content of this phospholipid are responsible for
mitochondrial dysfunction in a variety of pathological settings [110-113]. This concept is
illustrated by the fact that disruption in the association of CcO with cardiolipin was
accompanied by a ~50% reduction in activity of the enzyme [109]. Upon peroxidation,
cardiolipin undergoes redistribution to the outer mitochondrial membrane [114] where it
is required for release of apoptotic proteins from mitochondria into the cytosol [115].
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These effects could contribute to decreased CcO activity, impaired mitochondrial
respiration, and mitochondrial failure.
Eventually, these pathologic alterations in mitochondrial function affect cellular
functions and ultimately lead to cell death. Alterations in mitochondrial function are
potent signals for induction of cell death cascades.

Additionally, ROS have been

implicated in directly activating cell death cascades. For example, under conditions of
persistent impaired respiration, mitochondrial (type II) apoptosis is induced, with the
release of apoptogenic factors (including cytochrome c) from the mitochondria
purportedly serving as the final and irreversible trigger of neuronal death.
3.4 Delayed Neuronal Death: An Apoptotic-Like Phenotype
Cell death is often classified as apoptotic or necrotic, however, following cerebral
ischemia/reperfusion, cell death often proceeds in a manner distinct from traditional
apoptosis or necrosis. Morphologic and biochemical analysis indicate that both necrotic
and apoptotic events occur simultaneously [84, 116], and evidence linking various
pathways suggests that a degree of crosstalk exists that results in cell death occurring
in a spectrum between apoptosis and necrosis [117].

The most common form of

delayed, ischemia/reperfusion-induced neuronal cell death, and the type of insult that is
the focus of the mechanism detailed in this Chapter, is characterized by an apoptoticlike phenotype. While all the specific characteristics of apoptosis may not be present, a
key step – specifically, the release of apoptogenic factors from the mitochondria –
appears critical in the initiation of cell death cascades [64, 118-120].
Many mechanisms have been proposed to explain the release of cytochrome c
from mitochondria. Historically, it was hypothesized that mitochondria simply swell and
burst, thereby releasing their contents into the cytosol. More recently, a large body of
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work has focused on the Bcl-2 family of proteins and their interactions as important
regulators of mitochondrial permeability to cytochrome c.

Of the Bcl-2 family, the

primary candidates proposed to be involved in outer membrane permeabilization appear
to be Bax and Bak; these proteins purportedly interact directly with mitochondria to
promote the release of cytochrome c and other apoptogenic proteins (e.g. AIF,
Smac/Diablo) [121, 122]. In addition, other investigators have focused on elucidating
the formation of so-called ‘permeability transition pores’ that would facilitate cytochrome
c release.
The caveat in all of these studies is that they are based on the premise that
cytochrome c and other apoptogenic proteins are free within the mitochondria and, thus,
could be released after pore formation or alterations in mitochondrial permeability.
However, there is evidence that release of cytochrome c is a two-step process,
involving 1) the release of proteins usually tethered to inner membrane by cardiolipin,
combined with 2) pore formation [123]. Indeed, cytochrome c is among the proteins
shown to be tethered to the inner mitochondrial membrane by cardiolipin [115, 124].
Exposure of mitochondria to ROS induces peroxidation followed by oxidation of
cardiolipin, thereby releasing cytochrome c into the intermitochondrial space [123].
Subsequently, upon pore formation or alterations in permeability, the liberated
cytochrome c is free to be released into the cytosol where it promotes formation of the
apoptosome (a complex containing cytochrome c, caspase 9, and Apaf-1) that activates
caspase 3. The apoptotic pathways activated following ischemia/reperfusion converge
on caspase-3, the downstream cysteine protease, leading to the cleavage of hundreds
of potential substrates within the brain and thus executing programmed cell death [125].
Indeed, activation of caspase-3, -8, and -9 have all been demonstrated to increase in

22
the brain following ischemia/reperfusion [116, 126-128].
The aforementioned sequence of events identify multiple points of possible
therapeutic intervention that, if appropriately targeted, could stop the progression of
delayed neuronal cell death and thereby salvage tissue from ischemia/reperfusion
injury.

For example, intervening at the level of apoptosis (including prevention of

mitochondrial outer membrane pore formation, cardiolipin peroxidation, or caspase
activation), should have therapeutic benefits. However, attempts to prevent apoptotic
cell death have revealed that multiple concurrent and redundant cell death pathways
can be activated, making specific targeting of individual mediators or single pathways of
apoptosis difficult or ineffective.

Therefore, a focus on upstream targets (that is,

molecular events that precede cytochrome c release) may yield a more logical and
robust therapeutic approach to neuroprotection.
4. Intervention at OxPhos or ∆Ψm as a Potent Method of Neuroprotection
Targeting ROS to reduce or prevent brain ischemia/reperfusion injury is one
potential strategy to target an early cell death signal. However, this method has been
met with numerous clinical failures [129]. To understand this seemingly surprising lack
of success, the traditional methodology for treatment of oxidative damage must be
taken into consideration.
Current studies have shown that during reperfusion, ROS production exceeds
the availability of endogenous antioxidants. Accordingly, previous attempts to design
treatment modalities have focused on bolstering cellular antioxidant defenses to correct
this imbalance. This strategy is primarily based on laboratory studies demonstrating
robust neuroprotection in transgenic animals designed to overexpress endogenous
mitochondrial antioxidants [104, 130-132].

These studies have provided substantial
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mechanistic insight into the pivotal role of ROS in cerebral ischemia/reperfusion injury.
However, attempts to translate this concept and administer ROS scavengers as a
clinical therapy have been futile [129]. This discrepancy could be explained by the
multitude of potential pitfalls inherent in delivery of pharmacologic scavengers and
antioxidants to the

brain during reperfusion, including difficulties in delivery, rapid

reaction kinetics due to the short half-life of ROS, multiple ROS generation sites, limited
cellular drug uptake, and failure to cross the blood-brain barrier [133, 134]. Despite
improvements in drug formulation and delivery, the efficacy of antioxidant strategies
seen in animal studies has, nonetheless, not been realized in human trials [135-138].
As an alternative to this antioxidant approach, a cornerstone of the paradigm
proposed by the Hüttemann and Sanderson labs is that interventions designed to
prevent ROS generation (rather than scavenge ROS) will avoid many of the
confounding issues associated with traditional scavenging techniques. In this regard,
hyperpolarization of ∆Ψm is a critical regulatory step in multiple pathologies, including
early reperfusion of multiple tissues [74, 80, 139].

Moreover, targeting of

hyperpolarization has been shown to be a cytoprotective [91, 140, 141].
4.1 Uncoupling of Mitochondrial Membrane Potential
Cells express mitochondrial proteins, i.e., uncoupling proteins (UCPs) that allow
H+ to cross the inner mitochondrial membrane down the proton gradient. This bypasses
ATP synthase and thus does not produce ATP by utilizing the proton gradient. The
physiologic role of these proton channels is typically associated with heat generation.
Recent studies have, however, found that UCPs have additional functions in the cell,
including stabilizing the ∆Ψm, thereby limiting electron escape and thus partial reduction
of O2 [75].

Interestingly, when UCPs were investigated in tissues where heat
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generation is not a primary function (such as brain), it was found that these proteins
render the brain resistant to ischemia/reperfusion injury. For example, Haines et al.
demonstrated that knockout of uncoupling protein 2 (UCP2) resulted in dramatically
larger infarcts after stroke [142]. The converse was also true: overexpression of UCP2
was associated with a decrease in ischemia/reperfusion-induced brain damage, ROS
generation, and induction of apoptosis after stroke [143]. Finally, pivotal data from
Teshima et al. demonstrated that increased expression of UCP2 prevented ROSinduced cell death by stabilizing ∆Ψm [144]. These findings suggest that uncoupling
proteins may play an important role in mitochondria by stabilizing ∆Ψm to prevent
hyperpolarization and ROS production under stress. As a result, these proteins may
represent a potent target for therapeutic intervention.
In addition to the use of UCPs to stabilize the ∆Ψm, exogenous chemicals that
allow protons to cross the inner mitochondrial membrane have also been tested to
prevent ischemia/reperfusion injury. Proton ionophores (agents that allow proton leak
across the inner membrane), have been shown to be effective in multiple disease
states.

For example, mild mitochondrial membrane uncoupling reduced ∆Ψm

hyperpolarization, prevented ROS, and reduced cell death in models of myocardial
ischemia [141], traumatic brain injury [140], and peroxide-induced neuronal damage
[92].
It is important to note that small concentrations of mitochondrial membrane
uncoupling agents are profoundly protective whereas, in contrast, higher concentrations
exacerbate cellular damage [145].

These studies are consistent with the proposed

mechanism of ischemia/reperfusion injury discussed in this Chapter: mild membrane
uncoupling will prevent the hyperpolarization of ∆Ψm during stressful conditions, while
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complete uncoupling would allow excessive proton escape across the inner membrane
and result in an energetic crisis.

This biphasic effect makes the use of these

compounds potentially dangerous, as overdose of an uncoupling agent could
dramatically compromise the ability to produce energy through OxPhos.

These

compounds would also need to be present in the mitochondria during the time window
of ∆Ψm hyperpolarization. As the majority of studies suggest that this phenomenon
occurs during the early seconds-minutes of reperfusion [93], delivery to tissue prior to
reperfusion may pose a therapeutic barrier. However, as discussed in the following
section, there are potential methods capable of attenuating ∆Ψm hyperpolarization that
do not require pharmacologic delivery.
4.2 Ischemic Preconditioning
Ischemic preconditioning is a phenomenon in which transient resistance to an
ischemic insult is conferred to a tissue following brief episodes of sub-lethal ischemia.
To investigate the effect of ischemic preconditioning on ∆Ψm, Liu and Murphy utilized a
customized laser scanning confocal microscope together with ∆Ψm-specific fluorescent
probes for real-time analysis of ∆Ψm in a mouse model of stroke [80]. The authors
found that hyperpolarization of ∆Ψm was evident immediately following reflow, and that
application ischemic preconditioning prevented ∆Ψm hyperpolarization and dramatically
reduced the extent of neurologic injury.
Of specific interest is the mechanism by which preconditioning can prevent ∆Ψm
hyperpolarization at the onset of reperfusion.

Dave et al. demonstrated that brief

episodes of antecedent preconditioning ischemia triggered the activation of PKC and
upregulated mitochondrial survival signaling [146].

Preconditioning applied prior to

global brain ischemia provided multiple beneficial effects to the mitochondria, including
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phosphorylation of multiple OxPhos complexes, reduction of ROS generation,
preservation of mitochondrial respiration during late reperfusion (the mitochondrial
dysfunction phase) – events that culminated in decreased cytochrome c release, the
putative trigger for apoptosis [146]. One could postulate that stimulation of cell signaling
pathways that enhance phosphorylation of OxPhos complexes and limit cytochrome c
release could promote controlled respiration and stabilize ∆Ψm. Alternatively, a sublethal ischemic event could induce OxPhos dephosphorylation on a small scale,
generate small amounts of ROS, and thereby stimulate survival signaling responsible
for maintaining phosphorylation.

If the activation of these kinases were increased

during the subsequent ‘lethal’ ischemic event, this could provide protection from ∆Ψm
hyperpolarization and ROS generation. In addition, preconditioning could induce the
expression of UCPs, thereby maintaining lower basal ∆Ψm levels and limiting
hyperpolarization. Indeed, Liu et al. demonstrated that preconditioning does increase
UCP2 expression in brain [147]. However, whether this increase in expression in UCP2
contributes to preconditioning-induced neuroprotection – and, the precise mechanism
by which preconditioning modulates ∆Ψm – remains unknown.
4.3 Induction of Cell Signaling to Induce OxPhos Phosphorylation
Our current knowledge of cytochrome c and CcO suggests that the primary role
of the phosphorylation sites discovered to date is to sustain controlled respiratory rates
and thereby prevent ∆Ψm hyperpolarization and ROS generation [54, 60, 62, 63, 66,
148]. Accordingly, it stands to reason that induction of cell signaling cascades that
induce phosphorylation or prevent dephosphorylation would provide some protective
effect. Evidence from our group has shown that phosphorylation of cytochrome c at
Tyr97 can be induced by insulin [63]. Moreover, insulin treatment was found to be
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neuroprotective in a model of global brain ischemia/reperfusion by preventing the
release of cytochrome c from mitochondria and inducing the upregulation of PI3K and
other cell survival signaling cascades [64, 149].

Whether phosphorylation of

cytochrome c at Tyr97 contributes to insulin-induced neuroprotection by stabilizing ∆Ψm
is a focus of current investigation by our group.
5. Conclusions
This

Chapter

presents

an

overarching,

mitochondrial-centric

hypothesis

describing the mechanisms that underlie mitochondrial ROS generation and cell death
induced by reperfusion of ischemic brain tissue. There is evidence to support this injury
mechanism in multiple scenarios of cerebral ischemia/reperfusion injury including
stroke, cardiac arrest followed by resuscitation, and hypoxic-ischemic damage. The
crux of the hypothesis is that ∆Ψm hyperpolarization and the ensuing ROS burst cause
oxidative damage that precedes apoptosis in these pathologies. Specifically, our group
has proposed that: 1) ischemia induces dephosphorylation of OxPhos, thereby 2)
priming the mitochondria for hyperactive electron transport and ∆Ψm hyperpolarization
upon reperfusion, 3) initiating a burst of ROS which overwhelms endogenous
antioxidant systems that 4), damages cellular components and 5) culminates in the
initiation of apoptotic-like cell death cascades. Most notably, this paradigm suggests
that stabilization of ∆Ψm during early reperfusion provides a novel strategy to limit ROS
generation and attenuate ischemia/reperfusion induced to brain.
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CHAPTER 2
Infrared Light Therapy: a Novel Approach for Attenuating Cerebral Reperfusion
Injury
1. Rationale
Cerebral ischemia, sustained after cardiac arrest, is a major cause of death and
disability [1-4].

Similarly, hypoxic events encountered during the perinatal period

leading to pathologic decreases in fetal cerebral oxygen availability are detrimental
resulting in neonatal hypoxic-ischemic encephalopathy (HIE) [13-15]. The current and
only established and approved treatment to limit tissue damage and improve outcome
after cerebral ischemia is prompt restoration of blood flow to the ischemic areas [150].
However (and as discussed in Chapter 1), while timely reflow is essential for the
salvage of ischemic neurons, reperfusion can promote ROS production and lead to
significant, irreversible tissue damage as a result of resuscitation/reoxygentation [151].
Many pharmacologic approaches have aimed at attenuating reperfusion injury by
ROS scavenging.

However, this approach has yielded inconsistent results in

experimental models and failed to translate into the clinic, possibly due to the intrinsic
impediments in delivering adequate concentrations of scavengers to the subcellular
site(s) within the crucial early seconds-minutes of reflow. Thus, ongoing work in our
laboratory, and by others, seeks to address this unmet need for an effective treatment
of reperfusion injury by examining the preclinical efficacy of a novel non-invasive
method.

This approach relies on the ability of infrared light (IRL) to attenuate the

production of (rather than scavenging) ROS. Unlike ultraviolet and visual light, IRL
within the range of 700-1000nm readily passes through biological tissues [152, 153] and
thus circumvents a major inherent limitation of traditional pharmacology-based
treatments of reperfusion injury.
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1.1 Non-invasive Modulation of Mitochondrial Activity Using Infrared Light
The concept that IRL may be of therapeutic benefit and modulate mitochondrial
function is not entirely new, and previous studies have used IRL as a non-invasive
therapy [154-160]. Efficacy has been demonstrated for multiple pathologies including
nerve regeneration, peripheral neuropathy, stroke, and wound healing [156, 161-169];
however, results have often been contradictory likely owing to an incomplete
understanding of IRL’s mechanism of action[170-173].
Work form the Hüttemann laboratory has demonstrated that IRL can directly
modulate cytochrome c oxidase (CcO) activity in vitro (Figure 2-1). This tendency for
photobiomodulation of CcO activity likely stems from the various heme and copper
centers within the enzyme.

These

centers are influenced by light and
directly modulate enzyme function [174,
175]. IRL with a wavelength of 750nm or
950nm was found to attenuate CcO
activity, and this effect is exaggerated
when used in combination. In contrast,
IRL

with

modestly
consistent

a

wavelength

increased
with

of

810nm

CcO

activity,

previous

reports

examining this IRL wavelength [156,
160].

Figure 2-1: Modulation of CcO activity by IRL.
Percent change in the activity of isolated bovine CcO
in response to various IRL wavelengths alone or in
combination is shown Data were obtained after 3 min
of irradiation using low-power diodes and activities
were normalized to non-irradiated samples. IRL with
a wavelength of 750nm or 950nm attenuated CcO
activity, and this effect is exaggerated when used in
combination. In contrast, IRL with a wavelength of
810nm modestly increased CcO activity. From
Hüttemann.
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1.2 IRL Attenuates Mitochondrial Membrane Hyperpolarization and ROS
Production In Vitro
As introduced in Chapter 1 of this dissertation, the primary function of the
mitochondrial ETC is to execute the transfer of electrons to O2. CcO catalyses the last,
and proposed rate limiting step in this process; the donation of electrons to O2, allowing
conversion of O2 and H+ to H2O. Electron flux through complexes I, III, and IV, is
coupled to pumping of H+ across the inner mitochondrial membrane. This pumping of
protons across the inner mitochondrial membrane constitutes the largest contributing
force of the mitochondrial membrane potential (∆Ψm), which represents the overall
charge difference across the inner mitochondrial membrane.

During reperfusion,

increases in ∆Ψm are believed to contribute to the generation of mitochondrial ROS.
Thus, modulation of CcO activity via irradiation with IRL may provide a direct means of
controlling ∆Ψm (and in turn ROS production) non-invasively.
Using live-cell imaging in conjunction with the ∆Ψm-specific fluorescent probe,
TMRM, the Sanderson laboratory observed that IRL irradiation with a wavelength of
950nm decreased ∆Ψm which quickly returned to control levels when irradiation was
discontinued (Figure 2-2 A). These results indirectly demonstrate the ability the 950 nm
wavelength of IRL to suppress ETC electron flux via its inhibitory effect on CcO. Using
this in vitro method, the effect of IRL irradiation during simulated ischemia-reperfusion
was examined using immortalized hippocampal neurons (HT22 cells). These studies
confirmed the hyperpolarization of ∆Ψm during the first 30 minutes of reoxygenation, as
predicted by the mechanism proposed above (Figure 2-2 B). Furthermore, as shown in
Figure 2-2 B, IRL irradiation with a wavelength of 950nm during the initial 30 minutes of
reoxygentaion attenuated mitochondrial membrane hyperpolarization.
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Figure 2-2: IRL modulates mitochondrial membrane
potential and attenuates reperfusion injury in
cultured neurons. A. Mitochondrial membrane potential
(∆Ψm) during irradiation with 950 nm IRL (live cells using
TMRM). B. ∆Ψm during the initial 30 min of
reoxygenation after 1h O2/glucose deprivation [OGD].
Expressed data are mean values of 96 live cell
fluorescent well readings *p < 0.05. C. % viability in
control cells, cells subjected OGD, and cells exposed to
OGD treated with either excitatory IRL (810 nm) or
inhibitory IRL (750 nm and 950 nm) wavelengths; *p <
0.05). From Sanderson.

The effect of IRL on neuronal cell
survival after exposure to simulated ischemiareperfusion

was

examined.

Cells

were

irradiated with IRL via fiber-optic light guides
for the initial hour of reoxygenation and cell
death was quantified using a Live/Dead cell
viability assay 24 hours later. A reduction in
cell death was observed by irradiation with
inhibitory IRL wavelength (750 nm and 950 nm)
while the excitatory IRL wavelength (810 nm)
was not protective (Figure 2-2 C).

These

insights into the effect of IRL during simulated
ischemia-reperfusion in vitro have laid the foundation for subsequent in vivo efficacy
testing. Accordingly, focus was directed to examining the preclinical efficacy of IRL
using a rat model of adult global brain ischemia.
1.3 IRL Therapy Initiated at the Onset of Reperfusion Attenuates CA1
Hippocampal Damage Resulting from Global Brain Ischemia
Initial examination of the neuroprotective effect of IRL was evaluated in a rat
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model of adult global brain ischemia resulting from bilateral carotid-occlusion with
hypotension [64, 176-180]. This model leads neuronal injury occurring specifically in
populations of hippocampal CA1 neurons [5, 6].

These neurons are particularly

sensitive to ischemic insults, and a near-complete loss is observed at 3-7 days after
reperfusion [7, 8]. Consistent with previously published results using the rat model of
adult global brain ischemia, untreated control animals had a significant loss of CA1
hippocampal neurons 14 days after the injury (Figure 2-3). Representative images of
the CA1 hippocampus are shown in Figure 2-3 A, together with triple label
immunofluorescence to detect neurons, microglia, and astrocytes.

Quantification of

Figure 2-3: IRL treatment following
global brain ischemia attenuates CA1
hippocampal
damage.
A.
CA1
hippocampal damage. [bottom row] 10X
image
of
Cresyl
violet
stained
hippocampus
[middle
row]
40X
magnification of CA1 hippocampus, [top
row] Triple-label immuno-fluorescence for
NeuN (red-neuron marker), Iba-1 (greenmicroglia marker) and GFAP (astrocyte
marker). [Left column] Sham-operated
animal (Sham), [center column] 8 min
global brain ischemia followed by 14 days
reperfusion (GBI), [right column] GBI plus
IRL treatment (GBI + 950nm). B. Neuron
counts in the CA1 hippocampus (mean ±
SEM; *p<0.05 compared to GBI).
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CA1 neuronal counts is shown in Figure 2-3 B. When normalized to sham-operated
animals, global brain ischemia resulted in an 88% reduction in viable pyramidal neurons
and treatment with the CcO-inhibitory IRL wavelengths, 750 nm and 950 nm,
significantly attenuated CA1 hippocampal damage when used alone or in combination
(Figure 2-3 B). Treatment with the CcO-excitatory IRL wavelength, 810 nm, had no
effect on neuronal viability in CA1 hippocampus.
1.4 IRL Therapy Initiated at the Onset of Reperfusion Attenuates Mitochondrial
ROS Production within CA1 Hippocampal Neurons
In vitro studies outlined above suggest that inhibition of CcO at the onset of
reperfusion is associated with a favorable reduction in mitochondrial ROS generation.
To detect mitochondrial ROS generation in vivo, the fluorescent indicator MitoSOX®
was used [181]. This colorless probe accumulates in mitochondria and becomes a red
fluorescent dye upon oxidation. By pretreating rats with MitoSOX® via intra-carotid
artery infusion, the effect of IRL treatment on mitochondrial ROS production was
examined microscopically. As shown in Figure 2-4, inhibition of CcO at the onset of
reperfusion was successful in attenuating mitochondrial ROS production following

Figure 2-4: IRL treatment following global brain ischemia attenuates mitochondrial ROS
production. A. MitoSOX® fluorescence. Nuclei labeled with DAPI and mitochondrial ROS was
detected with MitoSOX® (red). [Left] sham-operated (Sham), [Center] global brain ischemia followed
by 30 min of reperfusion (GBI), [Right] GBI plus IRL treatment (GBI + 950 nm). (B) Quantitation of red
fluorescence (*p<0.05).
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cerebral ischemia. Representative fluorescent image overlays of the CA1 hippocampus
are shown in Figure 2-4A. Consistent with the proposed model, global brain ischemia
resulted in a significant increase in MitoSOX® fluorescence 30 minutes after the onset
of reperfusion when compared to non-ischemic sham-operated controls (Figure 2-4 B).
Furthermore, this increase in MitoSOX® fluorescence was abrogated in rats treated with
IRL (Figure 2-4 B).
2. Summary
These data provide evidence of the preclinical efficacy of IRL therapy for the
treatment of cerebral ischemia-reperfusion injury. As demonstrated above, treatment
with IRL wavelengths shown to reversibly inhibit CcO activity and reduce ∆Ψm in vitro
significantly improved neuronal survival after global brain ischemia in the adult rat.
Furthermore, IRL treatment initiated at the onset or reperfusion attenuated
mitochondrial ROS production. Thus, this therapeutic approach may provide a novel
means of neuroprotection by circumventing mitochondrial ROS-mediated cell death
signaling cascades.
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CHAPTER 3
Modeling Neonatal Hypoxic-ischemic Encephalopathy in the Rat
1. Rationale
The robust neuroprotective effect of IRL observed in the rat model of adult global
brain ischemia described in Chapter 2 demonstrates the utility of this treatment for
cerebral reperfusion injury. The specific goal of my dissertation is to investigate the
preclinical efficacy of this novel treatment paradigm in the neonatal brain – in
particular,brain injuries arising as a result of perinatal asphyxia. As a critical first step in
achieving this goal, Chapter 3 focuses on the evaluation and refinement of a widely
used animal model of neonatal hypoxic-ischemic encephalopathy (HIE).
The ‘Vannucci’ rodent model of neonatal HIE is a commonly employed method
based on the Levine preparation where unilateral common carotid artery ligation
followed by systemic hypoxia produces significant injury in the hypoxic-ischemic
cerebral hemisphere [182]. During the insult, systemic blood pressure and cerebral
blood flow ipsilateral to the carotid artery ligation are reduced by approximately 25%.
Although patency of the cerebral vasculature is maintained, hypoxia-ischemia results in
a drastic reduction in cerebral perfusion owing to a loss in the cerebral vessel’s
autoregulatory capacity. Accordingly, ipsilateral to the carotid artery ligation cerebral
perfusion pressure is reduced in proportion to the decline in systemic blood pressure.
Following cerebral hypoxia-ischemia in the neonatal rat, morphologic and
biochemical analysis indicate that both necrotic and apoptotic events occur which
ultimately contribute to cerebral infarction [84, 116]. The apoptotic pathways activated
following hypoxia-ischemia likely converge on caspase-3, which can be activated by the
intrinsic or extrinsic pathways [183].

As described in Chapter 1, under normal
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conditions mitochondrial ROS formation and degradation is balanced, thus, maintaining
overall mitochondrial redox stability.

During reperfusion following cerebral hypoxia-

ischemia, mitochondrial ROS accumulate which likely promote apoptotic cell death by
enhancing mitochondrial permeability leading to intrinsic activation of caspase-3
following the release of mitochondrial cytochrome c [184, 185].
The specific biochemical phenotype and extent of cerebral infarction in the rodent
model of neonatal HIE varies considerably from laboratory to laboratory and across
animal strains. Factors such as litter size and rodent diet, as well as the temperature
during and duration of the hypoxic insult contribute significantly to the model’s severity
and variability. The broad distribution in the extent of brain injury produced by this
model mandates that a large number of animal subjects be enrolled in a given study in
order to demonstrate any treatment effect [186].

The experiments described here

sought to evaluate the utility of the Vannucci rat model of neonatal HIE for use in our
laboratory by (i) establishing the extent of variability in cerebral injury achieved, as well
as (ii) determining the major biochemical conduit activated to promote cell death.
2. Materials and Methods
2.1 Reagents
All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless indicated
otherwise.
2.2 Animal Surgical Procedure.
Rat pups of either sex were subjected to HIE on postnatal day 7 using the Vannucci
model [182].

Briefly, pregnant female Sprague-Dawley rats were maintained in a

temperature controlled environment with a 12hr light/dark cycle and were allowed to
give birth naturally. To minimize variability in feeding and body weight, litters were size-
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culled to 10 pups on postnatal day 3. On postnatal day 7, pups were anesthetized
using isoflurane (3.0% induction, 1.5% maintenance) in NO2/O2 (1:1).

The right

common carotid artery was exposed via ventral midline neck incision and cut between
double ligatures of 6.0 silk suture. Sham operated control animals underwent the entire
surgical procedure except for ligation and cutting of the carotid artery. The incision was
sutured and pups were returned to their dam to recover for 60min before being exposed
to systemic hypoxia.
2.3 Hypoxia Chamber Design
Precise control of temperature during the hypoxic insult is critical in order to
minimize the variability in cerebral injury.

Accordingly, a custom designed hypoxia

apparatus was constructed. The inner chamber consisted of a 2.8 L polypropylene
container with an airtight removable lid equipped with a rubber gasket into which inlet
and exhaust ports were drilled. The inlet was connected to the glass barb of a 1L
Büchner flask via a 30 cm long section of polyethelene tubing with an internal diameter
of 0.635 cm. The inner chamber and Büchner flask were submerged in a Plexiglas
outer water bath (21L) with dimension of 33.3 cm (w) x 25.4 cm (h) x 45.7 cm (l) and a
wall thickness of 6mm (VWR Internationa; Radnor, PA).

During the insult, gas

containing 8% O2 (balanced in N2) was bubbled through the Büchner flask containing
750 mL of dH2O which served to warm and humidify the gas. Gas flow was maintained
at a rate of 2.5 L/min. Inner chamber air temperature was monitored using a t-type
digital thermocouple (Physitemp Instruments; Clifton, NJ).

The outer water bath

temperature was controlled by a submerged circulating water heater (Thermo Scientific;
Waltham, MA) and the water temperature was set to 36.2oC or 35.0oC to achieve an
inner chamber air temperature of 36.0±0.5oC or 34.5±0.5oC, respectively.
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Figure 3-1: Custom designed hypoxia apparatus. The apparatus consists of an inner chamber (1), gas
humidifier (2), water bath (3), and circulating water heater (4). Arrows indicate direction of gas flow.

2.4 Hypoxic Insult
After recovering from the carotid artery ligation surgery, pups were exposed to a
constant flow of humidified 8.0% ± 0.1% oxygen balance in nitrogen (AirGas USA;
Lansing, MI) in the custom-designed temperature-controlled chamber described above.
The effect of hypoxia chamber temperature was evaluated by maintaining chamber air
temperature at 34.5oC or 36.0oC and hypoxia was induced for 120 min or 180 min.
2.5 Infarct Volume Analysis
Forty-eight hours after the onset of reoxygenation, pups were euthanized via
deep anesthesia with isoflurane. Brain tissue was perfused transcardially with ice-cold
phosphate buffered saline, pH 7.4. Brains were removed and 1 mm coronal sections
were cut using a vibratome (Campden Instruments; Lafayette, IN). Brain slices were
immersed in 1% TTC in phosphate buffered saline, pH 7.4 and incubated at 37°C for 8
minutes [187]. Next, the slices were fixed in 4% paraformaldehyde overnight in the
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dark. Finally, TTC stained sections were scanned and (i) area of infarction (unstained
area), (ii) area of the ipsilateral hemisphere, and (iii) area of the contralateral
hemisphere were quantified using Quantity One ® software (Biorad).

The percent

infarcted area of each slice was determined by dividing the area of infarction (unstained
area) by the area of the ipsilateral hemisphere of each slice and infarct volume was
expressed as a percent of the ipsilateral hemisphere by summing the slices.
2.6 Subcellular Fractionation
To examine the effect of HIE on mitochondrial cytochrome c release and
caspase 3 activation, subcellular fractions were obtained from injured and shamoperated control animals using differential centrifugation for subsequent analysis via
western blot. At the indicated time points following the onset of reoxygenation, animals
were transcardially perfused with ice-cold PBS and ipsilateral (hypoxia-ischemia) and
contralateral (hypoxia-only) hemispheres were homogenized on ice in mitochondrial
Isolation buffer (HEPES 25mM; pH7.7, Sucrose 250mM, KFl 10mM, Vanadate 1mM,
EGTA 5mM, EGTA 2mM, PMSF 0.1mM). Following an initial centrifugation at 1000g
for 10 min at 4oC, the supernatant was centrifuged at 16,700g for 20min at 4oC to
isolate the crude mitochondrial fraction (pellet) and crude cytosolic fraction
(supernatant). For sham-operated controls, animals were sacrificed 5 hours after the
initial surgery (time-matched to 120 min reoxygenation).
2.7 Gel Electrophoresis and Immunoblotting
The protein concentration of mitochondrial and cytosolic fractions was
determined using the method described by Bradford [188] and 50 μg of protein was
loaded per lane and resolved via Tricine-SDS-PAGE as previously described [189].
Each gel was then transferred to a nitrocellulose membrane that was blocked with 5%
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nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20. Membranes were
incubated over night at 4oC with primary antibodies against cytochrome c (BD
Biosciences, San Jose, CA), cleaved caspase 3, VDAC, and GAPDH (Cell Signaling
Technology, Boston, MA). With the exception of anti-cleaved caspase 3, which was
diluted 1:500, all primary antibodies were diluted 1:1000. Bands were visualized using
horseradish peroxidase-conjugated secondary antibodies (Sigma-Aldrich, St Louis, MO)
and the scanned and digitalized films were analyzed using Quantity One ® software
(Biorad). Cytochrome c and cleaved caspase 3 immunoreactivity was normalized to
GAPDH or VDAC to control for protein loading of cytosolic and mitochondrial fractions,
respectively.
2.8 Statistical Analysis
All data were compared using Prism software (Graphpad; La Jolla, CA) and are
presented as means ± SEM. Following a test for normality, a one-way ANOVA was
performed and pairwise post-hoc comparisons were made using the Newman–Keuls
method. Infarct data from the 120 min hypoxic insult were not normally distributed;
accordingly, these data were analyzed using a Kruskal–Wallis one-way ANOVA by
ranks followed by Dunn’s post hoc analysis. P-values < 0.05 were considered
statistically significant.
3. Results
3.1 Hypoxia-ischemia Results in Substantial Infarction
In accordance with previous studies employing this model, rat pups subjected to
unilateral common carotid artery ligation followed by exposure to 8% oxygen sustained
cerebral infarction ipsilateral to the carotid artery ligation (Figure 3-2).

Importantly,

neither hypoxia nor carotid ligation alone produced a discernible injury. Infarction
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primarily affects the cerebral cortex, however involvement of subcortical regions
including the basal ganglia was also observed.
Figure 3-2: Hypoxia-ischemia results in substantial
cerebral infarction. Postnatal day 7 rats were subjected to
unilateral carotid artery ligation and subsequent hypoxia (8%
O2 balanced in N2; 180 min). Forty-eight hours after the onset
of reperfusion, brains were sliced and stained with TTC (Red=
viable tissue; unstained regions = infarction)

3.2 Temperature and Duration of the Hypoxic Insult Influence Mortality and Infarct
Severity in the Neonatal Rat Model of HIE
A total of 54 and 38 rat pups were enrolled to undergo 120 and 180 minutes of
hypoxia at 36C, with an additional 43 and 56 animals subjected to hypoxia at 34.5C.
Mortality following the shorter, 120 minute hypoxic insult was negligible (<3.7%),
irrespective of temperature (Figure 3-3 A). However, in animals assigned to receive
180 minutes of hypoxia, mortality was greater in animals maintained at 36C versus
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34.5C (36.8% versus 3.6%; Figure 3-3-A).

Figure 3-3. Temperature and duration of a hypoxic insult affect infarct volume and mortality. B.
Infarct volume expressed as a percent of the ipsilateral hemisphere measured 48 hours after cerebral
hypoxia-ischemia in the neonatal rat. Median infarct volume resulting from 180 minutes of hypoxia was
significantly greater than that caused by 120 minutes at chamber temperatures of 36.0oC and 34.5oC
(*P<0.05). Notably, chamber temperature had no significant effect on median infarct volume. A.
Comparison of % mortality for 120 and 180 minute hypoxic insults at chamber temperatures of 36.0oC
and 34.5oC.

Among survivors, ipsilateral median infarct volume resulting from 180 minutes of
hypoxia was significantly greater than that caused by 120 minutes regardless whether
the hypoxia chamber temperature was maintained at 36.0oC or 34.5oC (Figure 3-3 B).
Importantly, and in contrast to results obtained with 120 minutes of hypoxia, all animals
developed detectable (albeit variable) areas of infarction.
3.3 Cytosolic Accumulation of Cytochrome c is Associated with Increased
Caspase 3 Activation during Early Reperfusion Following Cerebral HypoxiaIschemia in the Neonatal Rat
Cytosolic accumulation of cytochrome c leads to activation of caspase-3 via the
intrinsic pathway resulting in apoptotic cell death. Accordingly, our next objective was to
determine whether this pathway is activated in the neonatal rat brain following a 180
minute hypoxic insult at 34.5°C – the conditions identified in Section 4.2 to consistently
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yield infarction with minimal mortality.

To address

this issue, cytosolic fractions obtained from ipsilateral
(hypoxic-ischemic) and contralateral (hypoxia-only)
hemispheres were collected at the end of hypoxiaischemia, as well as following 30 and 120 minutes of
reoxygenation (n=4-5 replicates per time-point).
Sham-operated animals time-matched to 120 min
reoxygenation were used as controls (n=4).

As

shown in Figure 3-4, western blot analysis revealed a
significant increase in cytochrome c accumulation
within the cytosolic fraction following 120 minutes of
reperfusion in the ipsilateral hemisphere (*P<0.05
versus sham).

Importantly, increased cytosolic

cytochrome c was not observed in the ipsilateral
hemisphere at earlier time points of reperfusion, nor
was increased cytosolic cytochrome c detected in the
contralateral hemisphere.
As shown in Figure 3-5 western blot analysis
of the catalytic cleavage of caspase 3 indicates that
this proapoptotic cysteine protease is activated
acutely in the brain, following hypoxia-ischemia in the
neonatal rat. Detection of cleaved caspase 3 within

Figure 3-4: Cytosolic accumulation of
cytochrome c following cerebral
hypoxia-ischemia in the neonatal rat.
A. Representative immunoblot for
cytochrome c and GAPDH in the
cytosol. Cytochrome c accumulation
was normalized to GAPDH, and
averaged data (mean ± SEM) are
shown for sham-operated control, at the
end of hypoxia-ischemia, as well as
following 30 or 120 min of reperfusion
from ipsilateral (B) and contralateral (C)
hemispheres. (*P<0.05)

the cytosol of the ipsilateral hemisphere was possible as early as 30 minutes following
the onset of reperfusion in two animals; and after 120 minutes of reperfusion all animals
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tested showed cleaved caspase 3 immunoreactivity confined to the ipsilateral
hemisphere.
Figure 3-5: Activation of caspase 3 following
cerebral hypoxia-ischemia in the neonatal rat. A.
Representative immunoblot for cleaved caspase 3
(17kd) and GAPDH in the cytosol. B. Cleaved
caspase 3 immunoreactivity was normalized to
GAPDH, and averaged data (mean ± SEM) are
shown for sham-operated control (Sham), at the end
of hypoxia-ischemia (End), as well as following 30 or
120 min of reperfusion from the ipsilateral
hemisphere. (*P<0.05)

4. Summary
Consistent with previously published literature, the extent of cerebral injury
produced by this rodent model of HIE was variable. Hypoxia chamber temperature had
an impact on mortality, but did not significantly change infarct volume with equal hypoxic
duration. These findings demonstrate the critical importance of maintaining a suitable
chamber temperature during the hypoxic insult when using this model. The duration of
the hypoxic event also influenced both the consistency of developing cerebral infarction
and median infarct volume, with larger infarcts observed with insults lasting 180 versus
120 minutes. While shorter hypoxic insults have been utilized in a small number of
studies by other groups [84, 190], pilot studies using 60 and 90 minutes of hypoxia
conducted using the chamber described above yielded no detectable infarct via TTC
staining 48 hours after the insult.
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Although, the distribution of ipsilateral infarct volumes among animals subjected
to either 120 or 180 minutes of hypoxia was broad, the longer hypoxic duration led to
infarct detection in all animals. Accordingly, a hypoxic insult of 180 minutes in duration
was chosen for use in examining mitochondrial permeability, cytosolic accumulation of
cytochrome c and activation of caspase 3.

To this end, hypoxia-ischemia, but not

hypoxia alone, led to significant cytosolic accumulation of cytochrome c within 2 hours
following the onset of reperfusion which was associated with caspase 3 activation.
Consequently, using a hypoxic duration of 180 minutes and a chamber temperature of
34.5oC, these findings suggest that the rat model of neonatal HIE causes mitochondrial
permeability transition and ultimately leads to the induction of apoptosis which,
presumably, contributes to the cerebral infarction observed.
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CHAPTER 4
Cardiolipin Oxidation and Hydrolysis in Neonatal HIE: Development and
Application of a Novel Mass Spectrometry Method
1. Rationale
Cardiolipins (CL) [bis-(1,2-diaceyl-sn-glycero-3-phospho)-1’-3’-sn-glycerols] form
a unique class of anionic phospholipid found nearly exclusively within the inner
mitochondrial membrane in eukaryotic cells.

CL influences a wider variety of

fundamental functions including mitochondrial inner membrane curvature [191] and
OxPhos supercomplex formation [192, 193].

Cleavage of CL by phospholipase A2

(PLA2) isoforms yields monolysocardiolipin (MLCL), which along with oxidized CL has
been implicated in apoptotic signaling and cell death [107, 194].
In adult rat models of acute traumatic brain injury and cerebral ischemiareperfusion, mitochondrial CL was observed to be selectively oxidized [195, 196].
Ongoing work by Kagan and collogues suggests that CL-oxidation occurs following the
transfer of electrons directly from reduced cytochrome c and newly oxidized CL is
hydrolyzed by calcium-independent PLA2 activity to form MLCL and oxidized free fatty
acids [196, 197].

This chapter focuses on: i) the development of a novel mass

spectrometry (MS) method for use in interrogating the integrity of mitochondrial CL; and
ii) the application of this method to investigate the effect of cerebral hypoxia-ischemia
on CL oxidation and hydrolysis using the neonatal rat model of HIE described in
Chapter 3.
2. Traditional Mass Spectrometry for the Analysis of Phospholipids
Commonly, MS platforms used to study membrane phospholipids, including CL,
are coupled to high-performance liquid chromatography and, more recently, to thin-layer
chromatography [198]. While the enrichment effect of chromatographic separation is
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often necessary when lipids of extremely low abundance are the targets for analysis,
these techniques require significant expertise and, importantly, introduce perturbations
arising from the extraction and separation conditions used.

Accordingly, ionization

methods for use in MS that enable lipid extraction to be avoided altogether are
emerging for use in lipid research [199-207].
Membrane phospholipids, including CL, are typically studied in the negative ion
mode using electrospray ionization (ESI) and matrix-assisted laser desorption/ionization
(MALDI)-MS. MALDI produces predominantly singly charged [M-H]- CL ions, whereas
ESI readily generates abundant doubly charged [M-2H]2- CL ions. ESI and MALDI are
considered to be ‘soft’ ionization methods, and MALDI is particularly important for
membrane lipid research applications because of its ability to ionize phospholipid
species directly from intact biological membranes and tissues without prior lipid
extraction [205]. Conversely, ESI is invaluable in lipidomics applications because of its
ease of coupling with liquid chromatography [208] and its multiple charging which
enhances the utility of ion mobility spectroscopy (IMS) and MS/MS applications.
Recently, alternative ‘soft’ ionization processes have been discovered for use in
MS that combine strengths of both ESI and MALDI. Specifically, desorption-ESI (DESI)
and laserspray ionization (LSI) readily generate multiply charged lipid ions and have
been successfully used analyze phospholipids directly from the surface of tissue slices
without lipid extraction [199, 209]. While substantial progress has been made using
these novel ‘soft’ ionization methods in platforms for lipid research, their reliance on
high-tech lasers or electrospray sources necessitates a reasonably high degree of skill
for successful implementation.

Conversely, matrix-assisted ionization (MAI) is a

recently described ‘soft’ ionization method capable of generating multiply charged ions
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[210-212].

The production of gas-phase ions is achieved through MAI matrix

sublimation upon exposure of the matrix/analyte crystalline solid to the vacuum,
inherent to mass spectrometers [212].

Owing to the sublimation-driven mechanism

underlying ion formation by MAI, there is no need for external energy input in the form of
laser ablation, electrospray voltages, or heat [212].
Within the last decade, ion mobility spectrometry (IMS)-MS has become an
important analytical method in lipid research with IMS providing an additional dimension
of gas-phase separation, analogous to liquid chromatography.

For complex lipid

mixtures like those found in the biological membranes, IMS-MS yields two-dimensional
separation in a timescale of a few milliseconds [213, 214]. Unlike high performance
liquid chromatography or thin layer chromatography, IMS provides real-time gas-phase
separation as ions travel through an ion-mobility cell, allowing lipid classes and
subclasses to be separated based on radial acyl chain length, degree of unsaturation
and head group variance [206, 207, 214]. Both ESI and MALDI have been successfully
coupled to IMS for lipid analysis; however, ionization methods that readily generate
multiply charged ions are more ideally suited for use in multidimensional IMS-MS
applications [213].

Additionally, given that IMS separation occurs in the gas-phase

following ionization, its use is amenable to research applications focused on studying
lipids from intact membranes where liquid-phase chromatography is unachievable.
The experiments described here, conducted in collaboration with Sarah Trimpin,
PhD (Department of Chemistry), sought to evaluate the use of MAI-IMS-MS as a
method for the characterization of CL species directly from intact mitochondrial
membranes. The success of this work is largely due to the recent discovery of a novel
MAI matrix, 1,2-dicyanobenzene (DCB).

Using DCB, the Trimpin laboratory has
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achieved MAI-MS sensitivities as low as 5 fmol with purchased cardiolipin standards
which is far superior to the sensitivities observed using the well-studied MAI matrix, 3Nitrobenzonitrile (3-NBN).
3. Technical Development of the MAI-IMS-MS Method
3.1 Materials and Methods
3.1.1 Reagents
All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless indicated
otherwise.
3.1.2 Mitochondrial Isolation
Technical

development

of

the

MAI-IMS-MS

method

development

and

characterization of the MS spectra was performed using mitochondria isolated from
naïve (nonischemic) heart, liver and brain of female retired breeder Sprague Dawley
rats. Briefly, tissue was homogenized on ice in mitochondrial Isolation buffer (Hepes
25mM; pH7.7, Sucrose 250mM, EGTA 5mM, EGTA 5mM).

Following an initial

centrifugation at 1000g for 10 min at 4oC, the supernatant was centrifuged at 16,700g
for 20min at 4oC to isolate the crude mitochondrial fraction (pellet). Mitochondria were
diluted to a protein concentration of 1mg•mL-1 in 20:80 H2O:EtOH containing 0.1%
NH4OH.
3.1.3 Matrix Assisted Ionization – Ion Mobility Spectrometry – Mass Spectrometry
The MAI matrix DCB (Alfa Aesar; Ward Hill, MA) was dissolved in acetonitrile
(5mg in 50µL) and mixed with enriched mitochondrial samples (1:1,v/v). Immediately
prior to analysis, the solution containing matrix and mitochondria was drawn into a pipet
tip in 1µL aliquots and allowed to crystallize at the end of the tip. As previously
described [210-212], samples were introduced directly into the vacuum of the mass
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spectrometer by placing the pipet tip against the skimmer cone inlet. Mass spectra
were obtained using a Waters SYNAPT G2 quadrupole-TOF and ion mobility
spectrometry was performed with N2 as the ion mobility gas.
3.2 Results
3.2.1 Multidimensional MAI-IMS-MS Analysis of Mitochondrial Cardiolipin
The MAI matrix DCB performed well in the presence of mitochondrial isolation
buffer with minimal chemical background, and no appreciable effect on ion abundance,
charge state or ion adduction was observed in the negative mode. Figure 4-1c shows a
two-dimensional plot of ion mobility drift time vs. mass-to-charge (m/z) ratio obtained
from rat brain mitochondria via MAI-IMS-MS.

Molecular ions fall along two clearly
Figure 4-1: MAI-IMS-MS of rat
brain
mitochondria.
Mass
spectra
of
a)
rat
brain
mitochondria and b) doubly
charged [M-2H]2- MLCL and CL
species extracted using IMS drift
time. c) Two-dimensional plot of
IMS
drift
time
vs.
m/z.
Multidimensional
IMS-MS
analysis enables doubly charged
[M-2H]2- and singly charged [MH]- ions to be cleanly separated.
The zoomed spectra highlight
the
extensive
isotopic
overlapping of doubly charged
[M-2H]2- and singly charged [MH]- ions which is eliminated
through the use of IMS drift time
deconvolution.

discerned trend lines determined by charge state where singly charged [M-H]- ions have
longer drift times compared to doubly charged [M-2H]2- ions. As seen in Figure 4-1a,
the mass spectra obtained from rat brain mitochondria is complex, and significant
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overlapping of singly charged [M-H]- phospholipid ions with the doubly charged [M-2H]2CL ions occurs between m/z 650-850. Deconvolution using IMS drift time enables the
mass spectrum of the doubly charged [M-2H]2- monolysocardiolipin (MLCL) and CL ions
to be easily extracted (Figure 4-1b) from the two-dimensional plot.

Figure 4-2: MAI-IMS-MS/MS characterization of cardiolipin species from brain mitochondria. a)
MAI-IMS-MS/MS spectra of the doubly charged [M-2H]2- CL precursor ion at m/z 749.5 from rat brain
mitochondria. Fatty acid fragment ions ([FA]-) at m/z 253.2, 281.2, 303.2 and 327.2 correspond to
palmitoleic (C16:1), oleic (C18:1), arachidonic (C20:4) and docosahexaenoic (C22:6) acids, respectively.
Monoacylglycerol phosphate ([MGP]-) fragment ions are observed at m/z 389.2, 417.2, 439.2, and 436.2.
Doubly charged [M-2H]2- triacyl-monolyso-cardiolipin fragment ions ([MLCL]2-) formed from the neural
loss of a ketene, and singly charged [M-2H]- triacyl-monolyso-cardiolipin fragment ions ([MLCL]-) are also
observed. b) Two-dimensional plot of IMS drift time vs. m/z showing two precursor ions at m/z 749.5 with
distinct IMS drift times were selected in the quadrupole and subjected to CID fragmentation. Using IMS
drift time, fragment ions originating from the doubly charged [M-2H]2- CL precursor ion with a drift time of
5.86 milliseconds (white box) are cleanly separated from those originating from the singly charged [MH]- precursor ion with a drift time of 9.26 milliseconds.

As anticipated, gas phase lipid ions generated during MAI matrix sublimation
yield ESI-like fragmentation spectra during tandem MS using collision-induced
dissociation (CID). The fragmentation spectra of tetra-linoleoyl-cardiolipin (Avanti Polar
Lipids; Alabaster, AL) obtained using MAI-, ESI- and MALDI-MS/MS were compared
(data not shown).

Independent of the ionization method used, characteristic

monoacylglycerol phosphate, diacylglycerol phosphate, and fatty acid fragment ions
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were observed. Additionally, the doubly charged [M-2H]2- CL precursor ions generated
by MAI and ESI, yielded a doubly charged [M-2H]2- triacyl-monolyso-cardiolipin
fragment ion resulting from the neutral loss of a ketene.
MAI-IMS-MS/MS characterization of CL species from mitochondrial samples is
achieved using IMS drift time as an additional dimension by which precursor ions
selected in the quadrupole can be isolated. Figure 4-2 shows the MAI-IMS-MS/MS
fragmentation spectrum generated during CID fragmentation of the doubly charged [M2H]2- CL precursor ion at m/z 749.5 of rat brain mitochondria. As observed in the 2dimensional plot, two ions with distinct IMS drift times were selected in the quadrupole
at m/z 749.5. Using IMS drift time, fragment ions origination from the doubly charged
[M-2H]2- CL precursor ion with a drift time of 5.86 milliseconds are cleanly separated
from those origination from the singly charged [M-H]- precursor ion with a drift time of
9.26 milliseconds.
Another noteworthy utility of IMS-MS is the rapid means of determining relative
abundance ratios using the drift time peak area. Consequently, the relative ratio of any
two lipid classes or subclasses, separated in the two-dimensional plot, can be easily
determined. Figures 4-3, 4-4 and 4-5 show the mass spectra of the major CL species
observed in rat heart, liver and brain mitochondria, respectively.

The various acyl-

groupings of CL are clustered based on the overall carbon content of their four acyl
chains.

The relative contribution of each acyl-grouping to the total CL pool was

determined using drift time. To do this, the drift time peak area for each acyl-grouping
was divided by the total CL peak area. These data are compared in Table 4-1.
In accordance with previously published results using traditional MS platforms
[215, 216], the diversity of mitochondrial CL species detected using MAI-IMS-MS was
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tissue- dependent.

The major CL species observed in the heart and liver were

composed of four 18-carbon acyl-chains. In the heart mitochondria this accounted for
81.3% of the total CL pool and was exclusively tetra-linoleoyl-cardiolipin (723.5 m/z;
CL72:8). In the liver mitochondria both tetra-linoleoyl-cardiolipin (723.5 m/z; CL72:8) as
well as tri-linoleoyl-mono-oleoyl-cardiolipin (724.5 m/z; CL72:7) were detected which
together comprised 53.1% of the total CL pool. The CL profile of brain mitochondria
contained more CL species than either the heart or liver mitochondria, and many of the
brain CL species were comprised of long acyl chains including arachidonic (C20:4) and
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Figure 4-3: MAI-IMS-MS spectra of the cardiolipin content of rat heart mitochondria. The enlarged
spectra highlight the isotopic distribution within each acyl-grouping.
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Figure 4-4: MAI-IMS-MS spectra of the cardiolipin content of rat liver mitochondria. The enlarged
spectra highlight the isotopic distribution within each acyl-grouping.
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Figure 4-5: MAI-IMS-MS spectra of the cardiolipin content of rat brain mitochondria. The enlarged
spectra highlight the isotopic distribution within each acyl-grouping.
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Table 4-1: Relative contribution of major cardiolipin Acyl-groupings observe in isolated
mitochondria

% of Total Cardiolipin Peak Area
Acyl-Grouping

Heart
Mitochondria
(mean ± s.d.)

Liver
Mitochondria
(mean ± s.d.)

Brain
Mitochondria
(mean ± s.d.)

CL 68:x
CL 70:x
CL 72:x
CL 74:x
CL 76:x
CL 78:x
CL 80:x
CL 82:x
CL 84:x
CL 86:x
CL 88:x

not detected
2.1% ± 0.2%
81.3% ± 7.6%
6.1% ± 1.8%
4.9% ± 0.5%
not detected
not detected
not detected
not detected
not detected
not detected

3.7% ± 0.5%
13.7% ± 2.1%
53.1% ± 3.2%
16.2% ± 3.2%
6.8% ± 1.8%
6.4% ± 0.4%
not detected
not detected
not detected
not detected
not detected

1.2% ± 0.5%
4.9% ± 0.9%
5.1% ± 1.2%
20.2% ± 3.2%
21.8% ± 5.5%
16.3% ± 0.6%
11.3% ± 0.9%
5.6% ± 0.8%
2.8% ± 0.1%
1.1% ± 0.2%
0.5% ± 0.1%

4. Application of the Method in the Neonatal HIE Model
4.1 Materials and Methods
4.1.1 Induction of Cerebral Hypoxia-ischemia
Using MAI-IMS-MS, as described above, we next sought to determine whether
cerebral hypoxia-ischemia influenced the overall mitochondrial CL profile. Neonatal rat
pups of either sex were subjected to HIE on postnatal day 7 using the Vannucci model
[182].

As described in chapter 3, pups were anesthetized using isoflurane (3.0%

induction, 1.5% maintenance) in NO2/O2 (1:1) and the right common carotid artery was
exposed via ventral midline neck incision and cut between double ligatures of 6.0 silk
sutures. Sham operated control animals underwent the surgical procedure except for
ligation and cutting of the carotid artery.

The incision was sutured and pups were

returned to their dam to recover for 60 min before being exposed to a constant flow of
humidified 8% oxygen balance in nitrogen in the custom-designed temperature-
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controlled chamber described in chapter 3. Chamber air temperature was maintained at
34.5oC and hypoxia was induced for 180 min.
Using the methods described in Section 2.1.2, mitochondria were isolated from
ipsilateral (hypoxic-ischemic) and contralateral (hypoxia-only) cerebral hemispheres at
the end of hypoxia-ischemia, as well as following 30 and 120 minutes of reoxygenation.
Sham-operated animals time-matched to 120 min reoxygenation were used as controls.
MAI-MS-MS was performed as detailed in Section 2.1.3 and interrogated as in Section
2.1.1.
4.1.2 Statistical Analysis
MLCL:CL ratios were determined by integration of extracted drift time curves to
yield a peak area for CL and MLCL. The MLCL peak area was divided by the CL peak
area to obtain an MLCL:CL ratio. These data were then analyzed using Prism software
(Graphpad; La Jolla, CA) and are presented as means ± SEM. A one-way ANOVA was
performed and pair wise post-hoc comparisons were made using the Newman–Keuls
method.
4.2 Results
4.2.1 Cerebral Hypoxia-ischemia Increases the MLCL:CL Ratio
As shown in Figure 4-6, hypoxia-ischemia resulted in a significant increase in the
MLCL:CL ratio during early reperfusion. Importantly, the increased MLCL:CL ratio was
observed exclusively in the ipsilateral hemisphere (hypoxic-ischemic), while in the
contralateral hemisphere (hypoxia-only) the ratio remained unchanged following the
insult and throughout reoxygenation (Figure 4-7).
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Figure 4-6: Cerebral hypoxia-ischemia leads to an increased ratio of MLCL:CL in mitochondria
following reoxygentation. a) Representative mass spectra of the doubly charged [M-2H]2- MLCL and CL
species observed in mitochondria of the ipsilateral cerebral hemisphere from a sham-operated control
animal [top row], an animal exposed the hypoxia-ischemia [middle row], and an animal exposed to
hypoxia-ischemia followed by 30 minutes of reperfusion [bottom row]. b) Extracted drift-time curves of
MLCL (4.78ms) and CL (5.68ms) from sham-operated control [top row], hypoxia-ischemia [middle row],
and hypoxia-ischemia + 30 minutes of reperfusion [bottom row]. c) An MLCL:CL ratio of each
mitochondrial sample, was determined by dividing MLCL peak area by the CL peak area. Averaged data
(mean ± SEM) are shown for sham-operated control (Sham), at the end of hypoxia-ischemia (End), as
well as following 30 or 120 min of reperfusion. (*P<0.05)
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Figure 4-7: Cerebral hypoxia has no effect on mitochondrial MLCL:CL ratio. a) Representative mass
spectra of the doubly charged [M-2H]2- MLCL and CL species observed in mitochondria of the
contralateral cerebral hemisphere from a sham-operated control animal [top row], an animal exposed the
hypoxia [middle row], and an animal exposed to hypoxia followed by 30 minutes of reoxygenation [bottom
row]. b) Extracted drift-time curves of MLCL (4.78ms) and CL (5.68ms) from sham-operated control [top
row], hypoxia [middle row], and hypoxia + 30 minutes of reoxygenation [bottom row]. c) An MLCL:CL ratio
of each mitochondrial sample, was determined by dividing MLCL peak area by the CL peak area.
Averaged data (mean ± SEM) are shown for sham-operated control (Sham), at the end of hypoxia (End),
as well as following 30 or 120 min of reoxygenationn. (*P<0.05)

5. Summary
5.1 Technical Advantages of the Method
The central role of membrane lipids in impacting cellular and subcellular
physiology is becoming more and more apparent; therefore, the ability to identify,
quantify and characterize membrane lipids directly from their native and intact biological
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membranes is of vital importance. While ESI is easily coupled to liquid chromatography
and is widely used in full-scale lipidomic studies, MALDI remains an attractive method
for many membrane lipid research applications because of its ability to ionize
phospholipid species without prior lipid extraction. MAI is a newly described ionization
method that provides a novel means of combining many of the strengths of ESI and
MALDI for use in studying membrane phospholipids. Unlike ESI and MALDI, where
significant technological knowledge is necessary for successful experimentation, MAI is
operationally simple and does not require the use of a laser or electrospray source.
Thus, MAI is compatible with a wide array of commercially available mass
spectrometers, requiring only the application of a MAI matrix such as 3-NBN or DCB.
5.2 Insights into Neonatal HIE
This work represents significant progress made in applying MAI-MS for the study
of the membrane phospholipid, CL, from intact and native mitochondrial membranes.
When used in conjunction with IMS-MS, this ionization method also provides a rapid
and effective means of obtaining the biologically significant MLCL:CL ratio through
analysis of extracted IMS drift time curves. Using this MAI-IMS-MS approach, cerebral
hypoxia-ischemia in the neonatal rat was shown to result in a significant increase in the
MLCL:CL ratio during early reperfusion.
While

CL

hydrolysis

during

cerebral

ischemia-reperfusion

may

occur

enzymatically following CL oxidation via PLA2 [217], it should be noted that in the
current study, no appreciable CL oxidation was detected using MAI-IMS-MS.
Subsequent MAI-IMS-MS/MS studies should be conducted to address this using an
untargeted screen for oxidized fatty acyl fragment ions arising from doubly charged [M2H]2- CL ions between m/z 650-850.

Chemically, however, CL hydrolysis during
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ischemia-reperfusion may occur as a result of nucleophilic catalysis directly, and to this
end, acid catalyzed CL hydrolysis has been reported [218, 219]. Independent of the
underlying mechanism, an increase in the MLCL:CL ratio is highly suggestive of
increased mitochondrial free radical production.
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CHAPTER 5
Preclinical Evaluation of Infrared Light Therapy Using a Rat Model of Neonatal
Hypoxic-ischemic Encephalopathy
1. Rationale
As presented in Chapter 2, evidence of the preclinical efficacy of IRL therapy for
the treatment of cerebral ischemia-reperfusion injury was initially obtained using a rat
model of adult global brain ischemia. Treatment with two IRL wavelengths shown to
reversibly inhibit CcO activity and reduce ∆Ψm in vitro (750 nm and 950 nm)
significantly improved survival of CA1 hippocampal neurons after global brain ischemia
in the adult rat while, in contrast, treatment with the CcO-excitatory IRL wavelength, 810
nm, had no effect on neuronal viability in CA1 hippocampus. Additionally, when initiated
at the onset of reperfusion, treatment with the CcO-inhibitory IRL wavelength, 950 nm,
attenuated mitochondrial superoxide production. These findings provide direct support
for the overarching hypothesis that reversible inhibition of CcO during early reperfusion
reduces mitochondrial ROS production and in turn confers neuroprotectection. The
experiments described here sought to evaluate the efficacy of this novel treatment
paradigm using the neonatal rat model of HIE characterized in the preceding two
chapters of this dissertation.
2. Materials and Methods
2.1 Reagents
All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless indicated
otherwise.
2.2 Induction of Cerebral Hypoxia-ischemia
Neonatal rat pups of either sex were subjected to HIE on postnatal day 7 using
the Vannucci model [182]. As described in Chapter 3, pups were anesthetized using
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isoflurane (3.0% induction, 1.5% maintenance) in NO2/O2 (1:1) and the right common
carotid artery was exposed via ventral midline neck incision and cut between double
ligatures of 6.0 silk sutures. The incision was sutured and pups were returned to their
dam to recover for 60 min before being exposed to hypoxia (i.e., a constant flow of
humidified 8% oxygen balanced in nitrogen) in the custom-designed temperaturecontrolled chamber described in Chapter 3. Chamber air temperature was maintained
at 34.5oC and hypoxia was induced for 180 min.
2.3 Administration of IRL Treatment
At the onset of reoxygenation, rat pups were immobilized by securing them to the
surface of 50 mm x 75 mm glass slides using laboratory tape, and animals were
transferred to a dry-air incubator (Thermo) held at 35.0oC. IRL was administered by
direct illumination through the skull via a LED device placed 5 cm from the dorsal scalp
(Figure 5-1). IRL treatment was conducted using low power, single-wavelength LED
diodes (Roithner Lasertechnology) emitting light with a wavelength of 750, 810, or 950
nm. IRL irradiation was initiated at the onset of reoxygenation and was continued for
120 min.
Figure 5-1: IRL administration. A.
Postnatal day 7 rat pup immobilized for IRL
treatment using a 50mm x 75mm glass slide
and laboratory tape. B. IRL emmiting LED
device equipped with single wavelength
diodes (Roithner Lasertechnology). C. IRL
administration of rat pups via direct
illumination of the skull using the LED
device.
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2.4 Infarct Volume Analysis
Infarct volume was determined 48 hours after the onset of reoxygenation via TTC
staining of the coronally sectioned brain and infarct volume was expressed as a percent
of the ipsilateral hemisphere as described in Section 2.5 of Chapter 3.
2.5 Subcellular Fractionation
Mitochondrial and cytosolic fractions were obtained 120 minutes following the
onset of reoxygenation from animals treated with IRL (750 nm) as well as from nontreated controls. Subcellular fractionation was achieved using differential centrifugation
as described in Section 2.6 of Chapter 3. Briefly, both the ipsilateral (hypoxia-ischemia)
and contralateral (hypoxia-only) hemispheres were homogenized on ice in mitochondrial
Isolation buffer (HEPES 25mM; pH7.7, sucrose 250mM, KFl 10mM, vanadate 1mM,
EGTA 5mM, EGTA 2mM, PMSF 0.1mM). Following an initial centrifugation at 1,000g for
10 min at 4oC, the supernatant was centrifuged at 16,700g for 20min at 4oC to isolate
the crude mitochondrial fraction (pellet) and crude cytosolic fraction (supernatant).
2.6 Gel Electrophoresis and Immunoblotting
The effect of IRL on HIE- induced accumulation of cytochrome c within the
cytosol and activation caspase 3 was evaluated using the western blotting technique
described in Section 2.7 of Chapter 3. Briefly, 50 μg of cytosolic protein was loaded per
lane and resolved via Tricine-SDS-PAGE. Primary antibodies against cytochrome c (BD
Biosciences, San Jose, CA), cleaved caspase 3, and GAPDH (Cell Signaling
Technology, Boston, MA) were used. With the exception of anti-cleaved caspase 3,
which was diluted 1:500, all primary antibodies were diluted 1:1000. Bands were
visualized using horseradish peroxidase-conjugated secondary antibodies (SigmaAldrich, St Louis, MO) and the scanned and digitalized films were analyzed using
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Quantity One ® software (Biorad).
2.7 Matrix Assisted Ionization – Ion Mobility Spectrometry – Mass Spectrometry
The effect of IRL treatment on the mitochondrial MLCL:CL ratio was evaluated
via MAI-IMS-MS as described in Section 3.1.3 of Chapter 4. Mitochondria were
obtained 120 minutes following the onset of reoxygenation from IRL-treated animals
and non-treated controls, and were diluted to a final protein concentration of 1mg•mL-1
in 20:80 H2O:EtOH containing 0.1% NH4OH. The MAI matrix DCB (Alfa Aesar; Ward
Hill, MA) was dissolved in acetonitrile (5mg in 50µL) and mixed with enriched
mitochondrial samples (1:1,v/v). Immediately prior to analysis, the solution containing
matrix and mitochondria was drawn into a pipet tip in 1µL aliquots and allowed to
crystallize at the end of the tip. As previously described in Chapter 4, samples were
introduced directly into the vacuum of the mass spectrometer by placing the pipet tip
against the skimmer cone inlet. Mass spectra were obtained using a Waters SYNAPT
G2 quadrupole-TOF and ion mobility spectrometry was performed with N2 as the ion
mobility gas.
3. Results
3.1 IRL Therapy Initiated at the Onset of Reperfusion Reduces Cerebral Infarct
Volume Following Hypoxia-ischemia in the Neonatal Rat
A total of 63 rat pups were enrolled to evaluate the effect of IRL treatment
following hypoxia-ischemia. Pups were randomly assigned to receive 120 min of IRLtreatment with a wavelength of 750, 810, or 950 nm (n=15, 15 and 16, respectively).
Non-treated littermates served as sham controls (n=17).
As shown in Figure 5-2, treatment with the CcO-inhibitory IRL wavelength, 750
nm, as well as the CcO-excitatory IRL wavelength, 810 nm, significantly attenuated
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cerebral infarction resulting from neonatal hypoxia-ischemia: mean infarct volumes were
31.3% and 29.0%, versus the value of 48.9% seen in untreated sham controls.
Treatment with the 950 nm IRL wavelength resulted in a mean infarct volume of 34.3%
which approached, but did reach, significance (p=0.127) when compared with controls.

Figure 5-2: IRL treatment attenuates cerebral infarction resulting from hypoxia-ischemia in the
neonatal rat. Postnatal day 7 rats were subjected to unilateral carotid artery ligation and subsequent
hypoxia (8% O2 balanced in N2; 180 min). Animals were randomly assigned to receive 120 min of IRLtreatment with a wavelength of 750, 810, or 950 nm. Non-treated littermates served as controls. Fortyeight hours after the onset of reperfusion, brains were sliced and infarct volume was assessed. A.
Representative TTC stained brain slices from a non-treated control and an IRL-treated animal (750 nm).
Red= viable tissue; unstained regions = infarction. B. Mean infarct volume for all IRL treatments as well
as non-treated controls (*p<0.05).

3.2 IRL Treatment Attenuates caspase 3 Activation during Early Reperfusion
Following Cerebral Hypoxia-ischemia in the Neonatal Rat
As demonstrated in Chapter 3, the neonatal rat model of HIE results in
mitochondrial permeability, cytosolic accumulation of cytochrome c and activation of
caspase 3 in the ipsilateral (hypoxic-ischemic) hemisphere within 2 hours following the
onset of reperfusion. Furthermore, using MAI-IMS-MS, cerebral hypoxia-ischemia in
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the neonatal rat was also shown to result in a significant increase in the mitochondrial
MLCL:CL ratio during early reperfusion (Chapter 4). Thus, we next sought to examine
whether the attenuation in cerebral infarction seen in the neonatal rat with IRL treatment
was associated with favorable reductions in mitochondrial cardiolipin hydrolysis,
mitochondrial permeability and caspase 3 cleavage.
Cytosolic fractions obtained from ipsilateral (hypoxic-ischemic) and contralateral
(hypoxia-only) hemispheres were collected from non-treated and IRL-treated animals
following 120 minutes of reoxygenation (n=4 per group). The wavelength of 750 nm
was used for IRL treatment, and irradiation was
initiated at the onset of reoxygenation and
maintained until the time of sacrifice (120 min).
Figure 5-3 shows the results of western blot
analysis of cytosolic cytochrome c accumulation
and caspase 3 cleavage in the ipsilateral
(hypoxic-ischemic) hemisphere of IRL-treated
and non-treated control animals. No difference in
cytosolic

cytochrome

c

accumulation

was

observed between IRL-treatment and control
Figure 5-3: Effect of IRL treatment on cytosolic
accumulation of cytochrome c and caspase 3
cleavage following cerebral hypoxia-ischemia in the
neonatal rat. A. Representative immunoblot for
cytochrome c, cleaved caspase 3, and GAPDH in the
cytosolic fraction obtained from the ipsilateral hemisphere
of IRL-treated and non-treated animals (control) subjected
to hypoxia-ischemia. Cytochrome c accumulation and
caspase 3 cleavage were normalized to GAPDH, and
averaged data (mean ± SEM) are shown for control and
IRL treated (750 nm) for cytochrome c (B) and cleaved
caspase 3 (C). (*P<0.05)
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(Figure 5-3 A).

However, cleavage of caspase 3 was nonetheless attenuated by

treatment with IRL (Figure 5-3 B).

As anticipated, no differences in cytosolic

cytochrome c accumulation or caspase 3 cleavage were observed in the non-injured
contralateral hemisphere between IRL-treated and non-treated control animals (data not
shown).
Using the MAI-IMS-MS approach described in Chapter 4, the effect of IRL on the
mitochondrial

MLCL:CL

ratio

following

hypoxia-ischemia

was

investigated.

Mitochondria were obtained from the ipsilateral (hypoxic-ischemic) hemisphere of nontreated and IRL-treated (750 nm) animals following 120 minutes of reoxygenation (n=4
per group). Given that the mitochondrial MLCL:CL ratio was previously found to be
unchanged in the contralateral (hypoxia-only) hemisphere using this rat model of
neonatal HIE (Chapter 4), the current study focused exclusively on the ipsilateral
(hypoxic-ischemic) hemisphere. Figure 5-4 A shows the mass spectra of the doubly
charged [M-2H]2- MLCL and CL species observed in mitochondria of the ipsilateral
cerebral hemisphere of a non-treated control animal as well as an animal treated with
IRL (750 nm) for 120min. The MLCL:CL ratio was determined by integration of the
extracted drift time curves for CL and MLCL, and the MLCL peak area was divided by
the CL peak area. Using this method, no significant difference in the MLCL:CL ratio
was observed between IRL-treatment and control (Figure 5-4 C).
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Figure 5-4: Mitochondrial MLCL:CL ratio following cerebral
hypoxia-ischemia is unaffected by IRL treatment. A.
Representative mass spectra of the doubly charged [M-2H]2- MLCL
and CL species observed in mitochondria of the ipsilateral cerebral
hemisphere from a non-treated control animal [top row] and an
animal treated with IRL (750 nm) for 120min [bottom row]. B.
Extracted drift-time curves of MLCL (4.78ms) and CL (5.68ms) from
control [top row] and IRL-treatment [bottom row]. C. Averaged data
(mean ± SEM) from control and IRL-treatment (750 nm); n=4 per
group.
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4. Summary
Consistent with results from previous IRL efficacy studies using a rat model of
adult global brain ischemia, IRL treatment using the CcO-inhibitory IRL wavelength, 750
nm, attenuated cerebral injury resulting from hypoxia-ischemia in the neonatal rat.
Furthermore, 750 nm IRL initiated at the onset of reperfusion, attenuated caspase 3
cleavage.
Experiments in the current chapter did, however, yield unexpected observations.
First, in contrast to data obtained in the adult rat model of global brain ischemia
(Chapter 2), treatment with the CcO-excitatory wavelength, 810 nm, reduced ipsilateral
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infarct volume in the neonate model. One potential explanation for this surprising result
is that alternative and as-yet unexplored mechanisms of neuroprotection may be elicited
by IRL therapy in the neonatal model of cerebral ischemia-reperfusion when compared
to the previously studied adult model.

These alternative mechanisms may work in

conjunction with, or independent of, the hypothesized mechanism of mitochondrial
modulation by CcO.

To this end, a divergence of CcO isoform expression within

mitochondria of the neonatal and adult brain may – in part – explain the discrepancy in
observations between the two studies. CcO isoform switching has been described in
lung mitochondria where CcO subunit IV isoforms 1 and 2 are preferentially expressed
in the immature and mature lung, respectively [220]. Future studies should evaluate the
effect of these specific IRL wavelengths (750, 810 and 950 nm) on CcO isolated from
neonatal brain mitochondria to determine how exactly neonatal CcO activity responds to
IRL irradiation in vitro.
It is also surprising that although neuroprotective, treatment with 750 nm IRL in
the current study had no effect on the mitochondrial MLCL:CL ratio as measured by
MAI-IMS-MS.

Previous in vitro and in vivo studies using this CcO-inhibitory IRL

wavelength support the hypothesis that 750 nm IRL treatment attenuates mitochondrial
ROS production during early reperfusion following ischemia (Chapter 2). As suggested
in Chapter 4, the mitochondrial MLCL:CL ratio may serve as an intrinsic indicator of
mitochondrial ROS production as CL hydrolysis to form MLCL likely occurs directly as a
result of – or enzymatically following – the production of mitochondrial ROS.
Nonetheless, using MAI-IMS-MS no detectable difference was observed in the
MLCL:CL ratio following cerebral ischemia-reperfusion between 750 nm IRL-treatment
and non-treated control. Similarly, no detectable difference in cytosolic cytochrome c

71
accumulation was observed between IRL-treatment and control. Subsequent studies
should be conducted to verify this initial observation and additional delayed time points
following the onset of reperfusion should be considered. It is possible that difference in
these and/or other biochemical outcomes may become more apparent between IRLtreatment and control as the cerebral injury evolves.
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CHAPTER 6
Discussion
1. Summary of Results
Ongoing work from the Hüttemann and Sanderson laboratories has provided the
fundamental mechanistic rationale for the use of IRL therapy as a treatment for cerebral
reperfusion injury.

The preclinical success of this approach stems from a

comprehensive understanding of the role of mitochondria in cell death caused by
cerebral ischemia-reperfusion injury. As summarized in Chapter 1, a model has been
proposed in which ischemic alterations of mitochondrial OxPhos primes the
mitochondria for subsequent reperfusion-induced ∆Ψm hyperpolarization leading to a
burst in mitochondrial ROS generation and loss of mitochondrial function.

These

mitochondrial alterations ultimately culminate in delayed neuronal death following the
release of proapoptotic factors from the mitochondria into the cytosol. This progression
is simplified into four main states that summarize the induction, progression, and
execution of cell death during brain ischemia-reperfusion: 1) ischemic starvation (i.e.,
ETC is rendered non-functional by the lack of O2); 2) reperfusion-induced
hyperactivation; 3) mitochondrial dysfunction; and 4) delayed neuronal death (Chapter
1, Figure1-2).
As discussed in Chapter 2, specific wavelengths of IRL can directly modulate
CcO activity. IRL with a wavelength of 750nm or 950nm was found to inhibit CcO
activity, while 810 nm IRL was found to modestly increased CcO activity (Chapter 2;
Figure 2-1). Given that CcO catalyses the final, and proposed rate limiting step in
mitochondrial electron transfer – the donation of electrons to O2 – modulation of CcO
activity via irradiation with IRL provides a novel mean of non-invasively regulating
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electron flux through the ETC and, by extension, the overall ∆Ψm. Treatment with IRL
wavelengths shown to inhibit CcO activity in vitro was associated with a favorable
reduction in mitochondrial ROS generation when initiated at the onset of reperfusion
following global brain ischemia in the adult rat and resulted in significant neuroprotection
(Chapter 2).
The overarching goal of this dissertation was to investigate the preclinical
efficacy of this novel treatment paradigm in the neonatal brain – in particular, brain
injuries arising as a result of perinatal asphyxia. Ischemic insults to the infant brain most
often result from prolapse or compression of the umbilical cord during delivery and
placental abruption [16-18]. Because these injuries are generally sustained while in a
hospital setting at the time of delivery, this patient population is much more likely to
receive therapeutic intervention early following the onset of reperfusion. Given that
∆Ψm hyperpolarization and mitochondrial ROS production likely occur rapidly following
the onset of reoxygenation, treatment of asphyxiated infants with IRL may provide a
non-invasive means of attenuating cerebral injury in this patient population.
The goal of the work described in Chapters 3 and 4 was to examine the utility of
the Vannucci rat model of neonatal HIE for use in the preclinical evaluation of IRL
therapy. Consistent with previously published literature, the extent of cerebral injury
produced by this rodent model of neonatal HIE was variable.

Not surprisingly, the

duration of the hypoxic event influenced both the consistency of cerebral infarction and
the median infarct volume. However, maintenance of a suitable chamber temperature
during the hypoxic insult was also demonstrated to be critical. Experiments reported in
Chapter 3 established that mitochondrial permeability, cytosolic accumulation of
cytochrome c and activation of caspase 3 were manifest acutely following cerebral
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hypoxia-ischemia, but not hypoxia-alone. Additionally, using the MAI-IMS-MS approach
described in Chapter 4, cerebral hypoxia-ischemia, but not hypoxia-alone, was shown to
result in a significant increase in the MLCL:CL ratio during early reoxygenation. This
latter observation is highly suggestive of mitochondrial ROS production, as CL
hydrolysis to form MLCL occurs directly as a result of (or enzymatically following) the
production of mitochondrial ROS. Taken together: although the inherent variability in
injury severity of this animal model necessitates that a large number of animal subjects
be enrolled in a given study in order to demonstrate any treatment effect, the acute
biochemical phenotype produced by HIE appears to progress in accordance with
predictions outlined in Chapter 1.

Specifically, mitochondrial ROS production and

mitochondrial permeability occur acutely following the onset of reoxygenation and
precede the activation of apoptosis.
Consistent with results from previous IRL efficacy studies using the adult global
brain ischemia, IRL treatment using the CcO-inhibitory IRL wavelength of 750 nm
attenuated cerebral injury resulting from hypoxia-ischemia in the neonatal rat.
Furthermore, IRL at 750 nm, initiated at the onset of reperfusion, attenuated caspase 3
cleavage. Unexpectedly, however, in contrast to data obtained in the adult rat model of
global brain ischemia, treatment with the CcO-excitatory wavelength, 810 nm, also
reduced ipsilateral infarct volume in the neonate model. As described in Chapter 5, one
potential explanation for this surprising result is that alternative responses to IRL
therapy may exist in the neonatal brain when compared to the mature brain.
2. Technical Limitations and Future Directions
One major limitation of this work stems from the inherent variability of cerebral
injury produced by this rat model of neonatal HIE. Despite the significant effort invested
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in optimization, cerebral infarct size among untreated controls ranged from a minimum
of 17.9% to a maximum of 83.5% of the ipsilateral hemisphere.

This substantial

variation confounds both the ability to identify therapies that will have a meaningful
effect on infarct size, and, as discussed below, yield mechanistic insights into these
therapies. Future preclinical studies investigating the optimal IRL wavelength and/or
wavelength combinations as well as the overall safety of this therapeutic approach
should be conducted in a large animal model.
Another significant limitation is that the mitochondrial MLCL:CL ratio has not
been validated empirically as an intrinsic indicator of mitochondrial ROS production.
While CL hydrolysis to form MLCL likely occurs directly as a result of (or enzymatically
following) the production of mitochondrial ROS, it is conceivable that this process may
occur enzymatically via a calcium-dependent PLA2 simply as a result of the
mitochondrial calcium loading that likely occurs during ischemic starvation (see Chapter
1 Section 3).

Ongoing work using isolated mitochondria seeks to address this

possibility in an attempt to better interpret the physiological significance of an increased
MLCL:CL ratio following cerebral ischemia-reperfusion.
As described in Chapter 5, using MAI-IMS-MS no detectable difference was
observed in the MLCL:CL ratio following cerebral ischemia-reperfusion between 750 nm
IRL-treatment and non-treated control. Similarly, no detectable difference in cytosolic
cytochrome c accumulation was observed between IRL-treatment and control. Given
the inherent variability in injury severity produced by this model, it is possible that these
unanticipated observations are merely the result of insufficient sampling (n=4 per
group), and that had a larger number of animals been enrolled (e.g. n =15-20 per
group), a treatment effect would have been detected.

This explanation (under-
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sampling) is strengthened further if a linear relationship is assumed to exist between
early biochemical outcomes (mitochondrial MLCL:CL ratio and cytosolic cytochrome c
accumulation) and cerebral infarct volume measured 48 hours after the onset of
reperfusion. Subsequent studies should be conducted to address this limitation.
Finally, the current study focused exclusively on biochemical events occurring
acutely following the onset of reperfusion while injury severity was assessed 48 hours
later. Future studies would benefit from adding additional endpoints at delayed time
points, as it is possible that pathophysiological and/or treatment-induced effects are
occurring as the cerebral injury evolves.
3. Conclusions
This work has provided two major technical contributions to the field of cerebral
ischemia-reperfusion injury. First, experiments in Chapter 3 have refined and provided
biochemical characterization of the rat model of HIE. Second, Chapter 4 focused on the
development of a method of characterizing membrane lipids directly from their native
and intact biological membranes without prior lipid extraction using the MAI-MS
technology pioneered in the Trimpin laboratory. While the current study used this new
method exclusively to investigate alterations in the CL profile of brain mitochondria
following cerebral hypoxia-ischemia, the approach can be employed in various
membrane lipid research applications. Finally, consistent with results from previous IRL
efficacy studies using a rat model of adult global brain ischemia, experiments in Chapter
5 establish that IRL treatment attenuated cerebral injury resulting from hypoxia-ischemia
in the neonatal rat. Thus, and perhaps most importantly, this work contributes to the
development of a potential novel therapeutic approach in the management of brain
injuries arising as a result of perinatal asphyxia.
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This work has provided two major technical contributions to the field of cerebral
ischemia-reperfusion injury. First, experiments in Chapter 3 have refined and provided
biochemical characterization of the rat model of HIE. Second, Chapter 4 focused on the
development of a method of characterizing membrane lipids directly from their native
and intact biological membranes without prior lipid extraction using the MAI-MS
technology pioneered in the Trimpin laboratory. While the current study used this new
method exclusively to investigate alterations in the CL profile of brain mitochondria
following cerebral hypoxia-ischemia, the approach can be employed in various
membrane lipid research applications. Finally, consistent with results from previous IRL
efficacy studies using a rat model of adult global brain ischemia, experiments in Chapter
5 establish that IRL treatment attenuated cerebral injury resulting from hypoxia-ischemia
in the neonatal rat. Thus, and perhaps most importantly, this work contributes to the
development of a potential novel therapeutic approach in the management of brain
injuries arising as a result of perinatal asphyxia.

108
AUTOBIOGRAPHICAL STATEMENT
Christian Andrew Reynolds
Education
2015

Ph.D. in Physiology, Wayne State University School of Medicine

2008–2010

Medical School, Universidad Autónoma de Guadalajara (non-degree)

2007

B.S., Microbiology, Oregon State University

Honors
2015
2010
2007

Lipids@Wayne Syposium Best Poster Award – 2nd Place
National Neurotrauma Society Student Travel Award
Tricore Reference Laboratories Extraordinary Achievement Award

Selected Peer-reviewed publications:
1. Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Hüttemann M. Molecular Mechanisms
of Ischemia-Reperfusion Injury in Brain: Pivotal Role of the Mitochondrial Membrane
Potential in Reactive Oxygen Species Generation. Molecular Neurobiology. 2013.
Feb;47(1):9-23.
2. Reynolds CA, Hüttemann M, Przyklenk K, Sanderson TH. Hypoxia-induced damage to the
adult and immature brain: molecular mechanism of oxidative damage and the need for
targeted therapeutic intervention. Hypoxia: Causes, Types and Management. Jan. 2013.
346:7-10
Manuscripts in preparation:
1. Sanderson TH, Wider J, Reynolds CA, Lepore B, Przyklenk K, Hüttemann M. Modulation
of Cytochrome c Oxidase Activity with Specific Infrared Light Wavelengths: Non-invasive
Therapy for Reperfusion Injury.
2. Reynolds, CA, Deleeuw, JL, Lutomski, CA, Sanderson, TH, Trimpin, S, Przyklenk, K, SolidState Direct Injection Mass Spectrometry enables Cardiolipin Characterization from Intact
Mitochondrial Membranes. Angewandte Chemie, in preparation
3. Reynolds CA, Przyklenk K, Hüttemann M, Sanderson, TH. Modulation of Cytochrome c
Oxidase Activity with Specific Infrared Light Wavelengths: Non-invasive Therapy for
Neonatal Hypoxic-Ischemic Encephalopathy
4. Reynolds, CA, Deleeuw, JL, Przyklenk, K, Trimpin, S, Sanderson, TH, Matrix Assisted
Ionization Vacuum Ion Mobility Spectrometry Mass Spectrometry provides Evidence for
Cardiolipin Remodeling Following Cerebral Hypoxia-Ischemia in the Neonatal Rat
5. Deleeuw, JL, Lutomski, CA, Reynolds, CA, Wager-Miller, J, Mackie, K, Trimpin, S. Rapid
Characterization of Lipids by Matrix-Assisted Ionization Ion Mobility Spectrometry Mass
Spectrometry.
Selected Research Support
Cardiovascular Research Institute - ISIS Grant Reynolds (Co-PI)
Dec 2014-Dec 2015
Cardiolipin modification as a central linchpin in mediating neonatal brain injury
Kellogg Foundation/WSU- Perinatology Virtual Reynolds (Co-PI)
Sept 2013-June 2015
A novel non-invasive infrared light-based therapy to attenuate neonatal hypoxic-ischemic
brain injury
Amer Heart Assoc Predoctoral Fellowship
Reynolds (PI)
July 2012-June 2014
Photobioinhibition of mitochondrial complex IV: a novel approach to reduce neonatal
cerebral ischemia/reperfusion injury”

